International Journal of Medical Sciences. Global reach, higher impact. Int J Biol Flavonodis ; 18 4 Man Wang 1Fei Yu 1Yuan Zhang qndWenguang Chang 1Meng Zhou 2. Institute for Translational Medicine, The Affiliated Hospital of Qingdao University, Cncer of Prrvention, Qingdao University, 38 Dengzhou Road, Qingdao,Shandong, China.
Hydrating and plumping of Dermatology, Qilu Hospital FoavonoidsCheeloo Athletes and gluten intolerance of Medicine, Shandong University, Pprevention Road, Anf,Shandong, China. E-mail: wangmanedu. cn; Meng Cancef, Department of Dermatology, Qilu Hospital QingdaoCheeloo Xnd of Medicine, Shandong University, Hefei Road, Qingdao,Shandong, China.
E-mail: zhoumengcom. Flavonoids are a prevfntion of polyphenolic compounds preventioj are ubiquitously found in plants and are Fkavonoids as part of the human diet in substantial amounts.
The verification of Flavnooids cancer chemopreventive benefits has led to a significant interest in this field. Gut microbiota includes a diverse community of microorganisms Endurance training tips has a close relationship Appetite control support group cancer development.
Increasing evidence Aging healthily guide indicated that flavonoids cxncer Hydrating and plumping abd by reshaping gut microbiota.
Gut microbiota can convert prwvention into bioactive Pre-workout supplements that possess anticancer activity. Here, Athletes and gluten intolerance, we present a brief introduction to gut microbiota and provide an overview of the Flavonoisd between gut microbiota and cancer pathogenesis.
We also highlight xnd crucial roles of flavonoids in preventing cancer based on their regulation cancwr gut microbiota. This review would Hydrating and plumping research on the flavonoid-intestinal prevenion interactions and clinical trials to validate the chemotherapeutic potentials of targeting gut microbiota rpevention dietary bioactive compounds.
Keywords : flavonoids, cancer, Flavonoirs benefits, gut microbiota, bioactive metabolites. Cancer prrevention become one ad the most Flavoonoids causes Flavonooids human morbidity and mortality around Flavnooids world [ 1 ].
Chemotherapy remains the mainstay of cancer treatment [ 2 ]. However, the use Memory enhancement techniques conventional chemotherapeutic agents has been linked with acquired cancer resistance and various preventipn side-effects.
Pdevention, significant efforts have been devoted to discovering new prveention and alternative therapeutic options. Natural compounds are attractive candidates canecr anticancer drug development on the count of their high availability, strong anticancerous efficiency czncer low toxicity.
Among natural compounds, flavonoids have Flavonoids and cancer prevention potential to be cancsr as anticancer agents, as many Flavonoidz have documented cabcer important roles in cancer chemoprevention and Caffeine from natures sources [ 34 ].
Flavonoids are a class of polyphenolic compounds in plants preventino for their color, andd and pharmacological properties [ 5 ]. Fruits, vegetables, nuts, legumes and plant-derived beverages e.
So preventioj, there are over structurally identified flavonoid molecules [ 6 ]. Their basic skeletal structure holds 15 carbon atoms Flavonoids and cancer prevention are arranged into a C preventiin -C preventoin -C 6 ring system [ Flavonnoids ].
Flavonoids are synthesized in plants as Flavonoids and cancer prevention secondary metabolites in response to stressors and play a critical role canncer protecting plants from be damaged by pathogens and insects [ 8 ].
After consumption, flavonoids are Hydrating and plumping metabolized by gut microbiota and host tissues. As a dietary Flavnoids, flavonoids are preventin to possess lFavonoids health-promoting properties, including antioxidant, anti-inflammatory, and anticancer effects.
According to previous findings, flavonoids exerted anticancer Flavonoids and cancer prevention via their regulation of cancer-relevant factors and pathways [ 9 ]. Recently, flavonoids are found to be preventuon in cancer Protein for sports nutrition by reshaping gut microbiota [ cacer ].
Bioactive metabolites produced by gut microbiota from preventiln exert an inhibitory effect on carcinogenesis [ 11 ]. The human gut is colonized by trillions of microorganisms including preventioj, bacteria, fungi, protozoa cqncer viruses, which preventin constitute the gut microbiota [ preventtion ].
The number of gut microbial cells is comparable to that of our own cells [ 13 ]. Gut microbiota mainly establishes a commensal relationship with the host [ 13 ].
They constitute an active living population that possesses a metabolic capability similar to the liver. The composition of gut microbiota exhibits wide interpersonal variation but relatively temporal stability in each individual [ 14 ]. Healthy individuals hold well-balanced, homeostatic gut microbiota.
Gut microbiota has been emerged as a crucial component of host metabolism and exerts various physiological functions, such as strengthening the integrity of intestinal mucosal barrier, offering nutrients, protecting against pathogens and orchestrating host immunity [ 15 ].
Particularly, gut microbiota participates in the pathophysiology of cancer via multiple mechanisms. The oncogenic Helicobacter pylori H. pylori has been found to be closely associated with gastric cancer.
Gut microbiota dysbiosis is another critical mechanism associated with carcinogenesis. Therefore, targeting gut microbiota could improve the efficacy of anticancer therapies [ 16 ].
In recent years, the impact of flavonoids on gut microbiota has become an active new frontier for cancer research, holding vital keys to understanding the mechanism of anticancer actions of flavonoids. Here, we present an overview of the reciprocal relationship between flavonoids and gut microbiota.
Also, we further describe the protective role of flavonoids against cancer via regulating gut microbiota. Although there are multitudinous studies revealing the anticancer mechanisms of action of flavonoids, substantial efforts on gut microbiota are still required to consider flavonoids as promising drug candidates in cancer prevention and treatment.
Gut microbiota refers to the microorganisms inhabiting the human gastrointestinal tract GIT. This dynamic community is a complex and diverse consortium of microorganisms comprising archaea, bacteria, fungi, protozoa and viruses. Thanks to the availability of multiomics studies and metagenome sequencing, our knowledge of gut microbiota has been rapidly expanding.
Approximately 10 14 microbial cells exist in the human gut, comparable to human cells [ 17 ]. Due to the emergence of internal transcribed spacer ITS ribosomal sequencing, fungi are also found in gut microbiota.
Healthy adult intestinal fungi are dominated by AspergillusCandidaDebaryomycesMalasseziaPenicilliumPichia and Saccharomyces [ 19 ]. Fungal communities are characterized by low biodiversity and great unevenness compared with bacterial inhabitants.
Fungi appear to pass through the GIT without inhabiting the GIT. It is proposed that Aspergillus and Penicillium are not stable GIT colonizers, but rather environmental or food-borne fungi. Phenotyping of fungal isolates showed that Candida albicans clung to human epithelial cells more efficiently and generated greater amounts of biofilm in vitro than non- Candida fungi [ 19 ].
Thus, C. albicans may be commonly implicated in stable colonization. Additional work is needed to verify if other species identified as potential inhabitants of the GIT, are genuine colonizers or rather reach the intestine spreading from other body districts.
Gut viruses consist of bacteriophages phages able to target intestinal bacteria, as well as eukaryotic viruses that replicate in host cells. Phages form the majority of gut viruses.
The complexity and diversity of human intestinal phages have been revealed by metagenomics. The families MyoviridaePodoviridae and Siphoviridae from the order Caudovirales are the major members of intestinal phages [ 2021 ].
Some studies reported the presence of other phage families in the gut, such as AnelloviridaeCircoviridaeInoviridae and Microviridae [ 22 ].
Phages affect the constitution and diversity of commensal bacteria in the intestine by modulating their mortality, acting as vehicles for horizontal gene transfer, or remodeling host metabolism [ 23 ].
Intestinal bacteria have evolved various defense mechanisms against phage infection. Generally, bacteria have acquired a sequence-specific adaptive immunity called clustered, regularly interspaced short palindromic repeat CRISPR system that protects organisms from invading phages [ 24 ]. Bacteria are able to hide their membrane receptors to restrict phage docking and replication [ 25 ].
Bacteria also prevent the dissemination of phages into adjacent cells via the 'abortive infection' mechanism [ 26 ].
Anelloviridae is the most prevalent eukaryotic DNA virus family in the gut, commonly in infants [ 27 ]. Other eukaryotic viruses, such as AdenoviridaeGeminiviridaeHerpesviridaeNanoviridaePapillomaviridaeParvoviridaePolyomaviridae and Poxviridaehave also been detected in the human gut [ 28 ].
Remarkably, pathogenic viruses e. In addition, gut RNA virome in the human GIT is mainly represented by plant- and insect-related viruses, including CaliciviridaePicobirnaviridaePicornaviridae and Reoviridae [ 28 ]. Enteric viruses and resident bacteria share the same environment within the intestine.
As a result, it has been proposed that the interplay between enteric viruses and other components of intestinal microbiota could have an impact on the course of enteric virus infection. Consistently, in vivo experiments proved that bacterial inhabitants facilitated the infectivity, propagation and transmission of enteric viruses [ 2930 ].
The promotion effects of microbiota on viral infection involve several mechanisms. The binding of viruses to bacterial components [e. Moreover, commensal bacteria confer immune evasion to enteric viruses. Intestinal microbiota inhibited interferon IFN -γ-dependent innate immune responses, thus contributing to immune tolerance of mice to norovirus [ 33 ].
On the contrary, intestinal microbiota can inhibit virus infection by priming antiviral immunity. For example, the commensal bacterium Blautia coccoides limited enteric virus replication and pathogenesis by mobilizing type I IFN-mediated antiviral innate immunity [ 34 ].
Metabolites of gut microbiota also control host immunity and viral infectivity. The previous study showed that Clostridium orbiscindens -produced metabolite desaminotyrosine could protect mice from influenza virus infection by activating type I IFN-mediated immune responses [ 35 ].
Indigenous commensal bacteria even block virus infection independent of host immune system in some circumstances. It turned out that Bacillus subtilis -produced peptide P18 exerted an inhibitory effect on influenza virus invasion in a murine infection model [ 36 ].
Thus, commensal microbiota plays dual roles in controlling enteric virus infection. Enteric viruses have an impact on the host immune system.
Gut viruses, especially phages, are able to trigger host innate immunity and thus protect against pathogenic infections [ 37 ]. The host immune system in turn has a key role in dominating the composition and expansion of resident viral communities in the intestine [ 38 ].
Furthermore, commensal viruses can control intestinal inflammation and contribute to intestinal homeostasis through TLR-mediated anti-inflammatory cytokine production [ 39 ].
Currently, the study on intestinal viruses is in its initial stage and there are still many gaps in our knowledge with regard to this field.
Particularly, standardized approaches for gut virome analysis are still lacking, and it is thus challenging to differentiate intrahost viral populations in the intestine from those responsible for acute infection.
Considerable efforts must be made to characterize the gut virome and to decipher the reciprocal crosstalk among intestinal microbes. In addition, longitudinal researches aimed at exploring the dynamics of the gut virome will be critical to advance our understanding of the exact mechanisms involved in the impact of gut microbiome on human health and disease.
: Flavonoids and cancer prevention| Metabolism | Dysbiosis signature of fecal microbiota in colorectal cancer patients. Kane M, Case LK, Kopaskie K, Kozlova A, MacDearmid C, Chervonsky AV. Phytoestrogen interaction with estrogen receptors in human breast cancer cells [J]. Institute for Health and Sport, Victoria University, Melbourne, , Australia. A chemical structure of compound is drawn for each flavonoid group Figure 2. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher. |
| The use of flavonoids in skin cancer prevention and treatment | The Flavonoids and cancer prevention proteins phospholipids scramblase 1 PLSCR1 and promyelocytic protein OMAD and social situations were F,avonoids after III treatment through activation of protein kinase Cδ Flavonoids and cancer prevention et prevenrion. These findings suggest that regulating miRNA cancerr is Athletes and gluten intolerance important mechanism-of-action of flavonoids in cancer treatment. Article CAS PubMed Google Scholar Ozdal T, Sela DA, Xiao J, Boyacioglu D, Chen F, Capanoglu E. A special interest on breast cancer stems from the fact that several flavonoids, particularly isoflavones, have also antioestrogenic effects So et al, ; Papas, Wogonin and its derivatives possess anticancer activity. Yin F, Giuliano AE, Van Herle AJ. Quercetin-Mediated Apoptosis and Cellular Senescence in Human Colon Cancer. |
| Flavonoid intake and breast cancer risk: a case–control study in Greece | British Journal of Cancer | Sorafenib is a multikinase angiogenesis inhibitor [ 9 ] used as first-line therapy in HCC. However, patients who initially benefit from sorafenib usually develop resistance within 6 months [ ]. A proposed mechanism of this resistance is the expression of the pregnane X receptor PXR or MDR-1, which is related to the elimination of sorafenib in HCC cells. Therefore, rhamentin decelerated the metabolic clearance of sorafenib and also sensitized HCC cells to the drug [ ]. Similarly, the combinatory treatment with apigenin potentiated the cytotoxicity of sorafenib in HCC HepG2 cells, as demonstrated through decreased cell viability, decreased migration and invasion, and increased apoptosis compared with single treatment groups [ ]. Also, Saraswati et al. As stated above, the disadvantage of TKIs usage is resistance; important mechanisms of the development of resistance include enhanced TKI efflux through efflux transporters such as BCRP [ 54 ]. Further, the flavonol kaempferol enhanced the chemotherapeutic efficacy of sorafenib against HCC demonstrated in silico and in vitro liver cancer HepG2 and N1S1 cells ; also, kaempferol reversed MDR by decreasing P-gp overexpression [ ]. Moreover, the flavonoid derivative WYC is a potential adjuvant agent against CDdriven urothelial carcinoma UC CSCs and could serve as a potent strategy against UC therapeutic resistance; among others, WYC declined EMT-CSCs markers such as MDR-1 or ABCG2 in vitro [ ]. HDACi is a novel class of small-molecular therapeutics that target the regulation of histone and non-histone proteins [ ]. The flavonol fisetin is a potential complementary agent in HDACi resistance, as it improves the chemosensitivity of HA22T, apicidin-resistant, and suberoylanilide hydroxamic acid-resistant SAHA-R HCC cells. Fisetin synergistically interacted with HDACi in parental cells and also resistant cell lines. Fisetin also promoted therapeutic potential in the xenograft model generated from HDAC inhibitor-resistant cells [ ]. Further, TRAIL is an immune cytokine of the TNF family that received attention as a targeted anti-cancer agent through the selective induction of apoptosis in cancer cells [ , ]. Mutations in DR4 and DR5, domains of death receptors associated with TRAIL-induced apoptosis, induce cancer cell resistance to TRAIL. Table 3 provides a summary of the mechanisms through which flavonoids enhance the therapeutic efficacy of targeted anti-cancer agents. Combinatorial and nanoparticulate approaches are suggested to overcome the challenges of resistance and severe side effects posed by monotherapies. Currently, the combinatory therapy of a chemotherapeutic agent and phytochemicals or chemotherapy and targeted therapy is an important tool to improved cancer patient management. Chemotherapy combined with targeted therapy is suggested to be effective especially for advanced NSCLC while EGFR is an essential target in NSCLC patients. Cetuximab, a monoclonal antibody targeting EGFR, is a first-line treatment for NSCLC, advanced colorectal cancer, and head and neck cancers. Indeed, cetuximab-functionalized nanostructured lipid carriers were developed for the co-delivery of paclitaxel and 5-demethylnobiletin a hydroxylated polymethoxyflavone from citrus and to avert dose-related adverse effects of anti-cancer agents. These nanostructured lipid carriers effectively inhibited tumor growth in a model of A paclitaxel-resistant cell-bearing mice [ ]. In conclusion, flavonoids represent an effective tool to improve the therapeutic outcomes of targeted anti-cancer strategies facing evident disadvantages such as insensitivity and resistance. After , cancer immunotherapy research introduced new monoclonal antibodies targeting tumor antigens and T-cell protein receptors to downregulate the immune response, specifically the immune checkpoint inhibitor monoclonal antibodies anti-cytotoxic T-lymphocyte-associated antigen 4 anti-CTLA4 and anti-programmed cell death protein 1 antibody anti-PD1. Monoclonal antibodies directed against immune checkpoint inhibitors include ipilimumab, nivolumab, and pembrolizumab [ 9 ]. Immunotherapy is a promising tool for cancer management, as it restores the anti-tumor immune response [ 15 ]. Not all patients respond to immunotherapy; thus, it is necessary to improve its efficacy [ 15 ]. Some level of immune escape and resistance is intrinsic to malignancies due to the development of most human tumors in an immune-competent environment. However, acquired resistance to immunotherapy can result from pre-existing genetic and epigenetic traits or de novo alterations of cancer cells or other tumor microenvironmental components. Thus, cancer cells can evade the immune response intrinsically loss or downregulation of target antigen expression, defective antigen presentation, insensitivity to immune effector molecules, upregulation of alternative immune checkpoints, and epigenetic alterations or via extrinsic mechanisms, which are mediated by non-cancer cells of the tumor microenvironment including tumor-associated macrophages TAMs , regulatory T cells Tregs , and myeloid-derived suppressor cells MDSCs [ ]. Programmed death ligand 1 PD-L1 is an essential immune checkpoint protein that binds to programmed death 1 PD-1 on T lymphocytes. Indeed, T cells exert an essential role in the eradication of cancer cells. However, cancer cells escape the immune response through PD-L1 expression. The binding of PD-L1 to PD-1 results in the inhibition of T-cell proliferation and activity, leading to tumor immunosuppression [ ]. Due to the ineffectiveness of immunotherapy and the experience of resistance in some cases, the antitumor efficacy of cancer immunotherapy needs to be increased. Thus, immunotherapeutic agents are often administered in combination with each other or with chemotherapeutic agents, radiotherapy, or surgery. Also, the combination of immunotherapy with antiangiogenic drugs yields promising outcomes [ 9 , ]. It is also essential to emphasize the potential of phytochemicals and their derivatives to improve cancer immunotherapy responses in the development of novel immunotherapeutic strategies [ , ]. As discussed below, the anti-cancer effects of flavonoids are also applicable in cancer immunotherapy either in combination with other agents or single agents [ 57 , 59 , , , , ]. Due to the frequent development of resistance to sorafenib, the first-line therapy for HCC, immune checkpoint inhibitors ICI such as nivolumab are studied as alternatives. However, due to the often unsuccessful outcomes of immunotherapy, the combinatorial approach seems to be a better choice to improve the treatment and to block immunosuppressive signals in the tumor microenvironment. Although the co-administration of VEGF inhibitors and ICI is associated with synergistic anti-cancer effects, it exerts several adverse effects. However, phytochemicals including flavonoids could improve the plant-based antiangiogenic-immunotherapy combination in HCC when compared with single compounds that are often associated with therapeutic failure [ ]. Furthermore, flavopiridol is a synthetic flavonoid that inhibits cyclin-dependent kinases [ ]. Although most chronic lymphocytic leukemia CLL patients receiving chemoimmunotherapy achieve complete remission, patients with significantly shortened progression-free intervals still represent an important obstacle. Also, minimal residual disease MRD occurs in a majority of CLL patients who relapse. Moreover, a phase I clinical trial demonstrated flavopiridol to be safe and efficient as consolidation therapy after chemoimmunotherapy in CLL patients [ ]. As discussed above, the immune escape of cancer cells is associated with PD-L1 expression [ ]. Also, the chemoresistance of nasopharyngeal carcinoma is associated with the upregulation of checkpoint inhibitor PD-L1, which is linked to enhanced aerobic glycolysis promoted by HIF1-α deregulation and LDH-A activity. Moreover, checkpoint blockade is an effective treatment of lung cancer; however, it often leads to resistance. Therefore, Tang et al. aimed to develop a new strategy to improve checkpoint blockade therapy. Eventually, dual inhibition of COX-2 and EGFR by melafolone improved PD-1 immunotherapy against Lewis lung carcinoma and CMT tumors; these results highlight its important role as a combinatory strategy against lung cancer by affecting vessels and immune cells [ 59 ]. Further, the prenylated flavonoid icaritin exerts potent anti-cancer activity by modulating multiple biochemical and cellular responses [ 58 ]. Advanced HCC is associated with limited treatment options. As the authors demonstrated in a phase I trial, the preliminary durable survival benefits of icaritin in advanced HCC patients correlated with its immuno-modulatory activities and immune biomarkers [ ]. Similarly, apigenin also suppressed PD-L1 in vitro in melanoma cells and in host dendritic cells; this potentiated the cytotoxicity of cocultured cytokine-induced killer cells against melanoma cells [ ]. In conclusion, flavonoids improve cancer immunotherapeutic effects either through increased efficacy of other anti-cancer agents or as potent single molecules modulating immune responses of cancer cells. Consequently, complex treatment models presenting concepts of predictive diagnostics followed by the targeted prevention and treatments tailored to the individualized patient profiles earn global appreciation as benefitting the patient, healthcare economy, and the society at large. In this context, application of flavonoids as a spectrum of compounds and their nano-technologically created derivatives is extensively under consideration, due to their multi-faceted anti-cancer effects applicable to the overall cost-effective cancer management, primary, secondary, and tertiary prevention. Conventional anti-cancer strategies demonstrate evident deficits. Despite recent progress in anti-cancer strategies, the development of a therapy resistance remains the leading cause of the cancer-related mortality. An improved understanding of carcinogenic processes allows for the technological innovation creating more efficient therapeutic modalities. Targeted anti-cancer therapies leverage unique molecular changes associated with specific cancer types. Anti-cancer protective application of flavonoids in the context of 3P medicine should follow principles of the evidence-based therapeutic effects, individualized prediction, targeted prevention and personalization of the treatment algorithms. To this end, application of specialized analytical approaches is strongly recommended such as liquid biopsy analysis, risk assessment tools, predictive and companion diagnostics, multi-omics and multi-parametric analysis, and application of artificial intelligence in medicine. Haneen Amawi, Charles R. Ashby Jr. Kucera R, Pecen L, Topolcan O, Dahal AR, Costigliola V, Giordano FA, et al. Prostate cancer management: long-term beliefs, epidemic developments in the early twenty-first century and 3PM dimensional solutions. EPMA Journal. Koklesova L, Liskova A, Samec M, Qaradakhi T, Zulli A, Smejkal K, et al. Genoprotective activities of plant natural substances in cancer and chemopreventive strategies in the context of 3P medicine. Article Google Scholar. Samec M, Liskova A, Koklesova L, Samuel SM, Zhai K, Buhrmann C, et al. Flavonoids against the Warburg phenotype—concepts of predictive, preventive and personalised medicine to cut the Gordian knot of cancer cell metabolism. EPMA J. Article PubMed PubMed Central Google Scholar. Liskova A, Samec M, Koklesova L, Kudela E, Kubatka P, Golubnitschaja O. Mitochondriopathies as a clue to systemic disorders—analytical tools and mitigating measures in context of predictive, preventive, and personalized 3P Medicine. Koklesova L, Samec M, Liskova A, Zhai K, Büsselberg D, Giordano FA, et al. Mitochondrial impairments in aetiopathology of multifactorial diseases: common origin but individual outcomes in context of 3P medicine. Solnier J, Fladerer J-P. Flavonoids: A complementary approach to conventional therapy of COVID? Phytochem Rev. Liskova A, Samec M, Koklesova L, Samuel SM, Zhai K, Al-Ishaq RK, et al. Flavonoids against the SARS-CoV-2 induced inflammatory storm. Biomed Pharmacother. Article CAS PubMed PubMed Central Google Scholar. Crigna AT, Samec M, Koklesova L, Liskova A, Giordano FA, Kubatka P, et al. Cell-free nucleic acid patterns in disease prediction and monitoring-hype or hope? Falzone L, Salomone S, Libra M. Evolution of cancer pharmacological treatments at the turn of the third millennium. Vanneman M, Dranoff G. Combining immunotherapy and targeted therapies in cancer treatment. Nat Rev Cancer. Chen HHW, Kuo MT. Improving radiotherapy in cancer treatment: Promises and challenges. Bukowski K, Kciuk M, Kontek R. Mechanisms of multidrug resistance in cancer chemotherapy. Koukourakis MI, Giatromanolaki A. Int J Radiat Biol. Article CAS PubMed Google Scholar. Baudino TA. Targeted cancer therapy: the next generation of cancer treatment. Curr Drug Discov Technol. Inthagard J, Edwards J, Roseweir AK. Immunotherapy: enhancing the efficacy of this promising therapeutic in multiple cancers. Clin Sci Lond. Article CAS Google Scholar. Pan S-T, Li Z-L, He Z-X, Qiu J-X, Zhou S-F. Molecular mechanisms for tumour resistance to chemotherapy. Clin Exp Pharmacol Physiol. Wang X, Zhang H, Chen X. Drug resistance and combating drug resistance in cancer. Cancer Drug Resistance. Liskova A, Samec M, Koklesova L, Giordano FA, Kubatka P, Golubnitschaja O. Liquid Biopsy is Instrumental for 3PM Dimensional Solutions in Cancer Management. Journal of Clinical Medicine. Grech G, Zhan X, Yoo BC, Bubnov R, Hagan S, Danesi R, et al. EPMA position paper in cancer: current overview and future perspectives. Kapinova A, Kubatka P, Liskova A, Baranenko D, Kruzliak P, Matta M, et al. Controlling metastatic cancer: the role of phytochemicals in cell signaling. J Cancer Res Clin Oncol. Kapinova A, Kubatka P, Golubnitschaja O, Kello M, Zubor P, Solar P, et al. Dietary phytochemicals in breast cancer research: anticancer effects and potential utility for effective chemoprevention. Environ Health Prev Med. Kubatka P, Kello M, Kajo K, Kruzliak P, Výbohová D, Šmejkal K, et al. Young Barley Indicates Antitumor Effects in Experimental Breast Cancer In Vivo and In Vitro. Nutr Cancer. Kubatka P, Kapinová A, Kello M, Kruzliak P, Kajo K, Výbohová D, et al. Fruit peel polyphenols demonstrate substantial anti-tumour effects in the model of breast cancer. Eur J Nutr. Kubatka P, Uramova S, Kello M, Kajo K, Samec M, Jasek K, et al. Anticancer Activities of Thymus vulgaris L. in Experimental Breast Carcinoma in Vivo and in Vitro. Int J Mol Sci. Kubatka P, Kello M, Kajo K, Samec M, Jasek K, Vybohova D, et al. Chemopreventive and Therapeutic Efficacy of Cinnamomum zeylanicum L. Bark in Experimental Breast Carcinoma: Mechanistic In Vivo and In Vitro Analyses. Article CAS PubMed Central Google Scholar. Kubatka P, Kello M, Kajo K, Samec M, Liskova A, Jasek K, et al. Rhus coriaria L. Sumac Demonstrates Oncostatic Activity in the Therapeutic and Preventive Model of Breast Carcinoma. Koklesova L, Liskova A, Samec M, Buhrmann C, Samuel SM, Varghese E, et al. Carotenoids in cancer apoptosis-the road from bench to bedside and back. Cancers Basel. Kubatka P, Kello M, Kajo K, Kruzliak P, Výbohová D, Mojžiš J, et al. Oregano demonstrates distinct tumour-suppressive effects in the breast carcinoma model. Kubatka P, Uramova S, Kello M, Kajo K, Kruzliak P, Mojzis J, et al. Antineoplastic effects of clove buds Syzygium aromaticum L in the model of breast carcinoma. J Cell Mol Med. Ashrafizadeh M, Ahmadi Z, Farkhondeh T, Samarghandian S. Resveratrol targeting the Wnt signaling pathway: A focus on therapeutic activities. J Cell Physiol. Ashrafizadeh M, Tavakol S, Ahmadi Z, Roomiani S, Mohammadinejad R, Samarghandian S. Therapeutic effects of kaempferol affecting autophagy and endoplasmic reticulum stress. Phytother Res. Ashrafizadeh M, Rafiei H, Mohammadinejad R, Afshar EG, Farkhondeh T, Samarghandian S. Autophagy regulation using luteolin: new insight into its anti-tumor activity. Cancer Cell Int. Ashrafizadeh M, Ahmadi Z, Mohammadinejad R, Ghasemipour Afshar E. Tangeretin: a mechanistic review of its pharmacological and therapeutic effects. J Basic Clin Physiol Pharmacol. Buhrmann C, Shayan P, Brockmueller A, Shakibaei M. Resveratrol suppresses cross-talk between colorectal cancer cells and stromal cells in multicellular tumor microenvironment: a bridge between in vitro and in vivo tumor microenvironment study. Buhrmann C, Popper B, Kunnumakkara AB, Aggarwal BB, Shakibaei M. Evidence that calebin a, a component of curcuma longa suppresses NF-B mediated proliferation, invasion and metastasis of human colorectal cancer induced by TNF-β Lymphotoxin. Bhia M, Motallebi M, Abadi B, Zarepour A, Pereira-Silva M, Saremnejad F, et al. Naringenin nano-delivery systems and their therapeutic applications. Zhai K, Brockmüller A, Kubatka P, Shakibaei M, Büsselberg D. Abotaleb M, Liskova A, Kubatka P, Büsselberg D. Therapeutic potential of plant phenolic acids in the treatment of cancer. Varghese E, Samuel SM, Abotaleb M, Cheema S, Mamtani R, Büsselberg D. Liskova A, Kubatka P, Samec M, Zubor P, Mlyncek M, Bielik T, et al. Dietary Phytochemicals Targeting Cancer Stem Cells. Riganti C, Contino M. New Strategies to overcome resistance to chemotherapy and immune system in cancer. Pintova S, Dharmupari S, Moshier E, Zubizarreta N, Ang C, Holcombe RF. Cancer Chemother Pharmacol. Lazzeroni M, Guerrieri-Gonzaga A, Gandini S, Johansson H, Serrano D, Cazzaniga M, et al. A presurgical study of lecithin formulation of green tea extract in women with early breast cancer. Cancer Prev Res Phila. Farsad-Naeimi A, Alizadeh M, Esfahani A, Darvish AE. Effect of fisetin supplementation on inflammatory factors and matrix metalloproteinase enzymes in colorectal cancer patients. Food Funct. Liskova A, Koklesova L, Samec M, Smejkal K, Samuel SM, Varghese E, et al. Flavonoids in Cancer Metastasis. Liskova A, Koklesova L, Samec M, Varghese E, Abotaleb M, Samuel SM, et al. Implications of flavonoids as potential modulators of cancer neovascularity. Article PubMed Google Scholar. Tang Q, Ma J, Sun J, Yang L, Yang F, Zhang W, et al. Genistein and AG synergistically increase the radiosensitivity of prostate cancer cells. Oncol Rep. Koh SY, Moon JY, Unno T, Cho SK. Baicalein Suppresses Stem Cell-Like Characteristics in Radio- and Chemoresistant MDA-MB Human Breast Cancer Cells through Up-Regulation of IFIT2. Li S, Zhao Q, Wang B, Yuan S, Wang X, Li K. Quercetin reversed MDR in breast cancer cells through down-regulating P-gp expression and eliminating cancer stem cells mediated by YB-1 nuclear translocation. Singh MP, Cho HJ, Kim J-T, Baek KE, Lee HG, Kang SC. Riahi-Chebbi I, Souid S, Othman H, Haoues M, Karoui H, Morel A, et al. The Phenolic compound Kaempferol overcomes 5-fluorouracil resistance in human resistant LS colon cancer cells. Sci Rep. Moradzadeh M, Tabarraei A, Sadeghnia HR, Ghorbani A, Mohamadkhani A, Erfanian S, et al. Kaempferol increases apoptosis in human acute promyelocytic leukemia cells and inhibits multidrug resistance genes. J Cell Biochem. Effect of 5,7-dimethoxyflavone on Bcrp1-mediated transport of sorafenib in vitro and in vivo in mice. Eur J Pharm Sci. Leu Y-L, Wang T-H, Wu C-C, Huang K-Y, Jiang Y-W, Hsu Y-C, et al. Hydroxygenkwanin suppresses non-small cell lung cancer progression by enhancing EGFR degradation. Chen Z, Tian D, Liao X, Zhang Y, Xiao J, Chen W, et al. Front Pharmacol. Sellam LS, Zappasodi R, Chettibi F, Djennaoui D, Yahi-Ait Mesbah N, Amir-Tidadini Z-C, et al. Silibinin down-regulates PD-L1 expression in nasopharyngeal carcinoma by interfering with tumor cell glycolytic metabolism. Arch Biochem Biophys. Bailly C. Molecular and cellular basis of the anticancer activity of the prenylated flavonoid icaritin in hepatocellular carcinoma. Chem Biol Interact. Tang H, Liu Y, Wang C, Zheng H, Chen Y, Liu W, et al. Inhibition of COX-2 and EGFR by Melafolone Improves Anti-PD-1 Therapy through Vascular Normalization and PD-L1 Downregulation in Lung Cancer. J Pharmacol Exp Ther. Nikolaou M, Pavlopoulou A, Georgakilas AG, Kyrodimos E. The challenge of drug resistance in cancer treatment: a current overview. Clin Exp Metastasis. Golubnitschaja O, Polivka J, Yeghiazaryan K, Berliner L. Liquid biopsy and multiparametric analysis in management of liver malignancies: new concepts of the patient stratification and prognostic approach. Gerner C, Costigliola V, Golubnitschaja O. Multiomic patterns in body fluids: technological challenge with a great potential to implement the advanced paradigm of 3P medicine. Mass Spectrom Rev. Fröhlich H, Patjoshi S, Yeghiazaryan K, Kehrer C, Kuhn W, Golubnitschaja O. Premenopausal breast cancer: potential clinical utility of a multi-omics based machine learning approach for patient stratification. Golubnitschaja O. Feeling cold and other underestimated symptoms in breast cancer: anecdotes or individual profiles for advanced patient stratification? Goldstein E, Yeghiazaryan K, Ahmad A, Giordano FA, Fröhlich H, Golubnitschaja O. Optimal multiparametric set-up modelled for best survival outcomes in palliative treatment of liver malignancies: unsupervised machine learning and 3 PM recommendations. Golubnitschaja O, editor. Ye Q, Liu K, Shen Q, Li Q, Hao J, Han F, et al. Reversal of Multidrug resistance in cancer by multi-functional flavonoids. Wong ILK, Zhu X, Chan K-F, Law MC, Lo AMY, Hu X, et al. Namdeo AG, Boddu SHS, Amawi H, Ashby CR, Tukaramrao DB, Trivedi P, et al. Flavonoids as Multi-Target Compounds: A Special Emphasis on their Potential as Chemo-adjuvants in Cancer Therapy. Curr Pharm Des. Hussain Y, Luqman S, Meena A. Research progress in flavonoids as potential anticancer drug including synergy with other approaches. Curr Top Med Chem. Abotaleb M, Samuel SM, Varghese E, Varghese S, Kubatka P, Liskova A, et al. Flavonoids in Cancer and Apoptosis. Samec M, Liskova A, Koklesova L, Mersakova S, Strnadel J, Kajo K, et al. Flavonoids Targeting HIF Implications on Cancer Metabolism. Article PubMed Central Google Scholar. Lv W-L, Liu Q, An J-H, Song X-Y. Scutellarin inhibits hypoxia-induced epithelial-mesenchymal transition in bladder cancer cells. Hsiao Y-H, Hsieh M-J, Yang S-F, Chen S-P, Tsai W-C, Chen P-N. Phloretin suppresses metastasis by targeting protease and inhibits cancer stemness and angiogenesis in human cervical cancer cells. Jiang C-H, Sun T-L, Xiang D-X, Wei S-S, Li W-Q. Anticancer activity and mechanism of xanthohumol: a prenylated flavonoid from hops Humulus lupulus L. Kozłowska A, Szostak-Wegierek D. Flavonoids—food sources and health benefits. Rocz Panstw Zakl Hig. PubMed Google Scholar. Kumar S, Pandey AK. Chemistry and biological activities of flavonoids: an overview. Panche AN, Diwan AD, Chandra SR. Flavonoids: an overview. Al-Ishaq RK, Abotaleb M, Kubatka P, Kajo K, Büsselberg D. Flavonoids and their anti-diabetic effects: cellular mechanisms and effects to improve blood sugar levels. Pichler C, Ferk F, Al-Serori H, Huber W, Jäger W, Waldherr M, et al. Xanthohumol Prevents DNA Damage by Dietary Carcinogens: Results of a Human Intervention Trial. Lievens Y, Borras JM, Grau C. Provision and use of radiotherapy in Europe. Mol Oncol. Taguchi K, Yamamoto M. The KEAP1-NRF2 System in Cancer. Front Oncol. Liu X, Sun C, Liu B, Jin X, Li P, Zheng X, et al. Genistein mediates the selective radiosensitizing effect in NSCLC A cells via inhibiting methylation of the keap1 gene promoter region. Takahashi A, Kubo M, Ma H, Nakagawa A, Yoshida Y, Isono M, et al. Nonhomologous End-Joining Repair Plays a More Important Role than Homologous Recombination Repair in Defining Radiosensitivity after Exposure to High-LET Radiation. Radiat Res. Tiwari P, Mishra KP. Flavonoids sensitize tumor cells to radiation: molecular mechanisms and relevance to cancer radiotherapy. Zhang Z, Jin F, Lian X, Li M, Wang G, Lan B, et al. Genistein promotes ionizing radiation-induced cell death by reducing cytoplasmic Bcl-xL levels in non-small cell lung cancer. Medhat AM, Azab KS, Said MM, El Fatih NM, El Bakary NM. Antitumor and radiosensitizing synergistic effects of apigenin and cryptotanshinone against solid Ehrlich carcinoma in female mice. Tumour Biol. Abdraboh ME, Essa ZS, Abdelrazzak AB, El-Far YM, Elsherbini Y, El-Zayat MM, et al. Radio-sensitizing effect of a cocktail of phytochemicals on HepG2 cell proliferation, motility and survival. Li Y, Wang Z, Jin J, Zhu S-X, He G-Q, Li S-H, et al. Quercetin pretreatment enhances the radiosensitivity of colon cancer cells by targeting Notch-1 pathway. Biochem Biophys Res Commun. Ma L, Zong X. Metabolic Symbiosis in Chemoresistance: Refocusing the Role of Aerobic Glycolysis. Wilkens S. Structure and mechanism of ABC transporters. Begicevic R-R, Falasca M. ABC Transporters in Cancer Stem Cells: Beyond Chemoresistance. Housman G, Byler S, Heerboth S, Lapinska K, Longacre M, Snyder N, et al. Drug Resistance in Cancer: An Overview. Januchowski R, Wojtowicz K, Zabel M. The role of aldehyde dehydrogenase ALDH in cancer drug resistance. Sakthivel KM, Hariharan S. Regulatory players of DNA damage repair mechanisms: Role in Cancer Chemoresistance. Salehan MR, Morse HR. DNA damage repair and tolerance: a role in chemotherapeutic drug resistance. Br J Biomed Sci. Liu R, Chen Y, Liu G, Li C, Song Y, Cao Z, et al. Lu X, Yang F, Chen D, Zhao Q, Chen D, Ping H, et al. Int J Biol Sci. Choi HJ, Heo JH, Park JY, Jeong JY, Cho HJ, Park KS, et al. Gynecol Oncol. Cho Y, Kim YK. Cancer Stem Cells as a Potential Target to Overcome Multidrug Resistance. Bahar E, Kim J-Y, Yoon H. Chemotherapy Resistance Explained through Endoplasmic Reticulum Stress-Dependent Signaling. Kim E-K, Jang M, Song M-J, Kim D, Kim Y, Jang HH. Redox-mediated mechanism of chemoresistance in cancer cells. Antioxidants Basel. Lan C-Y, Chen S-Y, Kuo C-W, Lu C-C, Yen G-C. J Food Drug Anal. Hassanzadeh P. Colorectal cancer and NF-κB signaling pathway. Gastroenterol Hepatol Bed Bench. Liu S, Li R, Qian J, Sun J, Li G, Shen J, et al. Mol Pharm. Bieg D, Sypniewski D, Nowak E, Bednarek I. Morin decreases galectin-3 expression and sensitizes ovarian cancer cells to cisplatin. Arch Gynecol Obstet. Zhang X, Huang J, Yu C, Xiang L, Li L, Shi D, et al. Quercetin Enhanced Paclitaxel Therapeutic Effects Towards PC-3 Prostate Cancer Through ER Stress Induction and ROS Production. Onco Targets Ther. Silbermann K, Shah CP, Sahu NU, Juvale K, Stefan SM, Kharkar PS, et al. Novel chalcone and flavone derivatives as selective and dual inhibitors of the transport proteins ABCB1 and ABCG2. Eur J Med Chem. Kong W, Ling X, Chen Y, Wu X, Zhao Z, Wang W, et al. Hesperetin reverses P-glycoprotein-mediated cisplatin resistance in DDP-resistant human lung cancer cells via modulation of the nuclear factor-κB signaling pathway. Int J Mol Med. Zhao L, Zhang W, Zhang F. Poncirin downregulates ATP-binding cassette transporters to enhance cisplatin sensitivity in cisplatin-resistant osteosarcoma cells. Scagliarini A, Mathey A, Aires V, Delmas D. Xanthohumol, a Prenylated Flavonoid from Hops, Induces DNA Damages in Colorectal Cancer Cells and Sensitizes SW Cells to the SN38 Chemotherapeutic Agent. Hua R, Pei Y, Gu H, Sun Y, He Y. J BUON. Fan X, Bai J, Zhao S, Hu M, Sun Y, Wang B, et al. Evaluation of inhibitory effects of flavonoids on breast cancer resistance protein BCRP : From library screening to biological evaluation to structure-activity relationship. Toxicol In Vitro. Wang Z, Sun X, Feng Y, Wang Y, Zhang L, Wang Y, et al. Dihydromyricetin reverses MRP2-induced multidrug resistance by preventing NF-κB-Nrf2 signaling in colorectal cancer cell. Darzi S, Mirzaei SA, Elahian F, Shirian S, Peymani A, Rahmani B, et al. Enhancing the Therapeutic Efficacy of Daunorubicin and Mitoxantrone with Bavachinin, Candidone, and Tephrosin. Evid Based Complement Alternat Med. Khonkarn R, Daowtak K, Okonogi S. Chemotherapeutic Efficacy Enhancement in P-gp-Overexpressing Cancer Cells by Flavonoid-Loaded Polymeric Micelles. AAPS PharmSciTech. Jabri T, Imran M, Aziz A, Rao K, Kawish M, Irfan M, et al. Design and synthesis of mixed micellar system for enhanced anticancer efficacy of Paclitaxel through its co-delivery with Naringin. Drug Dev Ind Pharm. Wang B, Guo C, Liu Y, Han G, Li Y, Zhang Y, et al. Novel nano-pomegranates based on astragalus polysaccharides for targeting ERα-positive breast cancer and multidrug resistance. Drug Deliv. Wen M, Xia J, Sun Y, Wang X, Fu X, Zhang Y, et al. Combination of EGFR-TKIs with chemotherapy versus chemotherapy or EGFR-TKIs alone in advanced NSCLC patients with EGFR mutation. Karachaliou N, Gonzalez-Cao M, Sosa A, Berenguer J, Bracht JWP, Ito M, et al. The combination of checkpoint immunotherapy and targeted therapy in cancer. Wang H, Pan R, Zhang X, Si X, Wang M, Zhang L. Abivertinib in patients with TM-positive advanced NSCLC and its subsequent treatment with osimertinib. Thorac Cancer. Huang S, Yu M, Shi N, Zhou Y, Li F, Li X, et al. Apigenin and Abivertinib, a novel BTK inhibitor synergize to inhibit diffuse large B-cell lymphoma in vivo and vitro. J Cancer. Harrison PT, Huang PH. Exploiting vulnerabilities in cancer signalling networks to combat targeted therapy resistance. Essays Biochem. Sambi M, Szewczuk MR. Introduction to the Acquisition of Resistance to Targeted Therapy. In: Szewczuk MR, Qorri B, Sambi M, editors. Current Applications for Overcoming Resistance to Targeted Therapies, Springer International Publishing: Cham, ; pp. Sabnis AJ, Bivona TG. Principles of Resistance to Targeted Cancer Therapy: Lessons from Basic and Translational Cancer Biology. Trends in Molecular Medicine. Groenendijk FH, Bernards R. Drug resistance to targeted therapies: Déjà vu all over again. Chen D-H, Zhang X-S. Targeted therapy: resistance and re-sensitization. Li X, Xu J, Tang X, Liu Y, Yu X, Wang Z, et al. Anthocyanins inhibit trastuzumab-resistant breast cancer in vitro and in vivo. Mol Med Rep. Zhang L, Qi Y, Xing K, Qian S, Zhang P, Wu X. Oncology Reports. Sim EH, Yang IA, Wood-Baker R, Bowman RV, Fong KM. Gefitinib for advanced non-small cell lung cancer. Cochrane Database Syst Rev. Trifolium Flavonoids Overcome Gefitinib Resistance of Non-Small-Cell Lung Cancer Cell by Suppressing ERK and STAT3 Signaling Pathways. Biomed Res Int. Liu J, Zhong T, Yi P, Fan C, Zhang Z, Liang G, et al. Tang W, Chen Z, Zhang W, Cheng Y, Zhang B, Wu F, et al. Gažák R, Fuksová K, Marhol P, et al. Preparative method for isosilybin isolation based on enzymatic kinetic resolution of silymarin mixture [J]. Process Biochem. Zhou J, Du G, Chen J. Novel fermentation processes for manufacturing plant natural products [J]. Curr Opin Biotechnol. Ross JA, Kasum CM. Dietary flavonoids: bioavailability, metabolic effects, and safety [J]. Annu Rev Nutr. Zhu Y, Liu Y, Zhan Y, et al. Preparative isolation and purification of five flavonoid glycosides and one benzophenone galloyl glycoside from psidium guajava by high-speed counter-current chromatography hsccc [J]. Molecules Basel, Switzerland. Markham KR. Isolation techniques for flavonoids [M]. In: Harborne JB, Mabry TJ, Mabry H, editors. The flavonoids. Boston: Springer; Cragg GM, Newman DJ. Natural products: a continuing source of novel drug leads [J]. Hossain MA, Mizanur Rahman SM. Isolation and characterisation of flavonoids from the leaves of medicinal plant orthosiphon stamineus [J]. Arab J Chem. Ferreyra MLF, Rius SP, Casati P. Flavonoids: biosynthesis, biological functions, and biotechnological applications [J]. Front Plant Sci. Koes RE, Quattrocchio F, Mol JN. The flavonoid biosynthetic pathway in plants: function and evolution [J]. Quattrocchio F, Baudry A, Lepiniec L, et al. The regulation of flavonoid biosynthesis [M]. The science of flavonoids. Berlin: Springer; Stobiecki M, Kachlicki P. Isolation and identification of flavonoids [M]. Gates MA, Vitonis AF, Tworoger SS, et al. Flavonoid intake and ovarian cancer risk in a population-based case-control study [J]. Int J Cancer. Gates MA, Tworoger SS, Hecht JL, et al. A prospective study of dietary flavonoid intake and incidence of epithelial ovarian cancer [J]. Molina-Montes E, Sanchez MJ, Zamora-Ros R, et al. Flavonoid and lignan intake and pancreatic cancer risk in the european prospective investigation into cancer and nutrition cohort [J]. Lei L, Yang Y, He H, Chen E, Du L, Dong J, Yang J. Flavanols consumption and cancer risk: a meta-analysis of epidemiologic studies. PubMed PubMed Central Google Scholar. Theodoratou E, Kyle J, Cetnarskyj R, et al. Dietary flavonoids and the risk of colorectal cancer [J]. Cancer Epidemiol Biomark Prev. Zamora-Ros R, Barupal DK, Rothwell JA, Jenab M, Fedirko V, Romieu I, Aleksandrova K, Overvad K, Kyro C, Tjonneland A, Affret A, His M, Boutron-Ruault MC, Katzke V, Kuhn T, Boeing H, Trichopoulou A, Naska A, Kritikou M, Saieva C, Agnoli C, Santucci de Magistris M, Tumino R, Fasanelli F, Weiderpass E, Skeie G, Merino S, Jakszyn P, Sanchez MJ, Dorronsoro M, Navarro C, Ardanaz E, Sonestedt E, Ericson U, Maria Nilsson L, Boden S, Bueno-de-Mesquita HB, Peeters PH, Perez-Cornago A, Wareham NJ, Khaw KT, Freisling H, Cross AJ, Riboli E, Scalbert A. Dietary flavonoid intake and colorectal cancer risk in the European prospective investigation into cancer and nutrition EPIC cohort. Shin A, Lee J, Lee J, et al. Isoflavone and soyfood intake and colorectal cancer risk: a case-control study in korea [J]. PLoS ONE. Article PubMed PubMed Central CAS Google Scholar. Zamora-Ros R, Not C, Guinó E, et al. Association between habitual dietary flavonoid and lignan intake and colorectal cancer in a spanish case—control study the bellvitge colorectal cancer study [J]. Woo HD, Kim J. Dietary flavonoid intake and risk of stomach and colorectal cancer [J]. World J Gastroenterol. Simons CC, Hughes LA, Arts IC, et al. Dietary flavonol, flavone and catechin intake and risk of colorectal cancer in the netherlands cohort study [J]. Hirvonen T, Virtamo J, Korhonen P, et al. Flavonol and flavone intake and the risk of cancer in male smokers finland [J]. Article Google Scholar. Nimptsch K, Zhang X, Cassidy A, et al. Habitual intake of flavonoid subclasses and risk of colorectal cancer in 2 large prospective cohorts [J]. Am J Clin Nutr. Kempkes M, Golka K, Reich S, et al. Glutathione s-transferase gstm1 and gstt1 null genotypes as potential risk factors for urothelial cancer of the bladder [J]. Arch Toxicol. Yu CP, Shia C-S, Tsai S-Y, Hou YC. Pharmacokinetics and relative bioavailability of flavonoids between two dosage forms of gegen-qinlian-tang in rats. Evid-Based Complement Altern Med. Heim KE, Tagliaferro AR, Bobilya DJ. Flavonoid antioxidants: chemistry, metabolism and structure-activity relationships [J]. J Nutr Biochem. Cai X, Fang Z, Dou J, et al. Bioavailability of quercetin: problems and promises [J]. Mauludin R, Müller RH, Keck CM. Kinetic solubility and dissolution velocity of rutin nanocrystals [J]. Eur J Pharm Sci. Gil-Izquierdo A, Gil MI, Ferreres F, et al. In vitro availability of flavonoids and other phenolics in orange juice [J]. Mandalari G, Tomaino A, Rich GT, et al. Polyphenol and nutrient release from skin of almonds during simulated human digestion [J]. Food Chem. King RA, Bursill DB. Plasma and urinary kinetics of the isoflavones daidzein and genistein after a single soy meal in humans [J]. Gee JM, DuPont MS, Day AJ, et al. Intestinal transport of quercetin glycosides in rats involves both deglycosylation and interaction with the hexose transport pathway [J]. Spencer JPE. Metabolism of tea flavonoids in the gastrointestinal tract [J]. Olthof MR, Hollman PC, Buijsman MN, et al. Chlorogenic acid, quercetinrutinoside and black tea phenols are extensively metabolized in humans [J]. In vitro metabolism of anthocyanins by human gut microflora [J]. Eur J Nutr. Winter J, Moore LH, Dowell VR Jr, et al. C-ring cleavage of flavonoids by human intestinal bacteria [J]. Appl Environ Microbiol. CAS PubMed PubMed Central Google Scholar. Gonthier MP, Verny MA, Besson C, et al. Chlorogenic acid bioavailability largely depends on its metabolism by the gut microflora in rats [J]. Kim DH, Jung EA, Sohng IS, et al. Intestinal bacterial metabolism of flavonoids and its relation to some biological activities [J]. Arch Pharm Res. Ueno I, Nakano N, Hirono I. Metabolic fate of [14c] quercetin in the aci rat [J]. Jpn J Exp Med. Boulton DW, Walle UK, Walle T. Fate of the flavonoid quercetin in human cell lines: chemical instability and metabolism [J]. J Pharm Pharmacol. Zhu H-J, Brinda BJ, Chavin KD, et al. An assessment of pharmacokinetics and antioxidant activity of free silymarin flavonolignans in healthy volunteers: a dose escalation study [J]. Drug Metab Dispos. Dixit N, Baboota S, Kohli K, et al. Silymarin: a review of pharmacological aspects and bioavailability enhancement approaches [J]. Indian J Pharmacol. Spencer JP, Schroeter H, Rechner AR, et al. Bioavailability of flavanols and procyanidins: gastrointestinal tract influences and their relevance to bioactive forms in vivo [J]. Antioxid Redox Signal. Gawande S, Kale A, Kotwal S. Effect of nutrient mixture and black grapes on the pharmacokinetics of orally administered - epigallocatechingallate from green tea extract: a human study [J]. Nunes T, Almeida L, Rocha JF, et al. Pharmacokinetics of trans-resveratrol following repeated administration in healthy elderly and young subjects [J]. J Clin Pharmacol. Decker EA. Phenolics: prooxidants or antioxidants? Nutr Rev. Fresco P, Borges F, Diniz C, et al. New insights on the anticancer properties of dietary polyphenols [J]. Med Res Rev. Křížková J, Burdová K, Stiborová M, et al. The effects of selected flavonoids on cytochromes p in rat liver and small intestine [J]. Interdiscip Toxicol. Jiang W, Hu M. Mutual interactions between flavonoids and enzymatic and transporter elements responsible for flavonoid disposition via phase ii metabolic pathways [J]. RSC Adv. Xiao J, Ni X, Kai G, et al. A review on structure—activity relationship of dietary polyphenols inhibiting α-amylase [J]. Crit Rev Food Sci Nutr. Xiao J, Kai G, Yamamoto K, et al. Advance in dietary polyphenols as α-glucosidases inhibitors: a review on structure-activity relationship aspect [J]. Xiao JB, Huo JL, Yang F, et al. Morris ME, Zhang S. Flavonoid—drug interactions: effects of flavonoids on abc transporters [J]. Life Sci. Duda-Chodak A, Tarko T, Satora P, et al. Interaction of dietary compounds, especially polyphenols, with the intestinal microbiota: a review [J]. Xiao J, Kai G. A review of dietary polyphenol-plasma protein interactions: characterization, influence on the bioactivity, and structure-affinity relationship [J]. Xiao J, Cao H, Wang Y, et al. Glycosylation of dietary flavonoids decreases the affinities for plasma protein [J]. J Agric Food Chemistry. Sun Y-L, Patel A, Kumar P, et al. Role of abc transporters in cancer chemotherapy [J]. Chinese J Cancer. Alfarouk KO, Stock C-M, Taylor S, et al. Resistance to cancer chemotherapy: failure in drug response from adme to p-gp [J]. Cancer Cell Int. Kathawala RJ, Gupta P, Ashby CR Jr, et al. The modulation of abc transporter-mediated multidrug resistance in cancer: a review of the past decade [J]. Drug Resist Updates. Klein I, Sarkadi B, Varadi A. An inventory of the human abc proteins [J]. Biochem Biophys Acta. Vasiliou V, Vasiliou K, Nebert DW. Human atp-binding cassette abc transporter family [J]. Hum Genom. Rice AJ, Park A, Pinkett HW. Diversity in abc transporters: type i, ii and iii importers [J]. Crit Rev Biochem Mol Biol. Chen Z, Shi T, Zhang L, et al. Mammalian drug efflux transporters of the atp binding cassette abc family in multidrug resistance: a review of the past decade [J]. Cancer Lett. Klappe K, Hummel I, Hoekstra D, et al. Lipid dependence of abc transporter localization and function [J]. Chem Phys Lipid. Murakami T, Takano M. Intestinal efflux transporters and drug absorption [J]. Expert Opin Drug Metab Toxicol. Russel FG. Transporters: Importance in drug absorption, distribution, and removal [M]. Enzyme-and transporter-based drug-drug interactions. Book Google Scholar. Alvarez AI, Real R, Pérez M, et al. Modulation of the activity of abc transporters p-glycoprotein, mrp2, bcrp by flavonoids and drug response [J]. J Pharm Sci. Cermak R, Wolffram S. The potential of flavonoids to influence drug metabolism and pharmacokinetics by local gastrointestinal mechanisms [J]. Curr Drug Metab. Gatouillat G, Magid AA, Bertin E, et al. Medicarpin and millepurpan, two flavonoids isolated from medicago sativa, induce apoptosis and overcome multidrug resistance in leukemia p cells [J]. Dash RP, Ellendula B, Agarwal M, et al. Increased intestinal p-glycoprotein expression and activity with progression of diabetes and its modulation by epigallocatechingallate: Evidence from pharmacokinetic studies [J]. Eur J Pharmacol. Wink M, Ashour ML, El-Readi MZ. Secondary metabolites from plants inhibiting abc transporters and reversing resistance of cancer cells and microbes to cytotoxic and antimicrobial agents. Front Microbiol. Schoonbeek HJ, Raaijmakers JM, De Waard MA. Fungal abc transporters and microbial interactions in natural environments [J]. Mol Plant Microbe Interact. Marzolini C, Paus E, Buclin T, et al. Polymorphisms in human mdr1 p-glycoprotein : recent advances and clinical relevance [J]. Clin Pharmacol Ther. Choi J-S, Han H-K. Enhanced oral exposure of diltiazem by the concomitant use of naringin in rats [J]. Int J Pharm. Ofer M, Wolffram S, Koggel A, et al. Modulation of drug transport by selected flavonoids: involvement of p-gp and oct? Spahn-Langguth H, Langguth P. Grapefruit juice enhances intestinal absorption of the p-glycoprotein substrate talinolol [J]. Brand W, Schutte ME, Williamson G, et al. Flavonoid-mediated inhibition of intestinal abc transporters may affect the oral bioavailability of drugs, food-borne toxic compounds and bioactive ingredients [J]. Li Y, Paxton JW. The effects of flavonoids on the abc transporters: consequences for the pharmacokinetics of substrate drugs [J]. Schexnayder C, Stratford RE. Genistein and glyceollin effects on abcc2 mrp2 and abcg2 bcrp in caco-2 cells [J]. Int J Environ Res Public Health. Article PubMed Central CAS Google Scholar. Bernardo J, Valentao P, Grosso C, et al. Flavonoids in neurodegeneration: Limitations and strategies to cross cns barriers [J]. Article PubMed CAS Google Scholar. Tan ZR, Zhou YX, Liu J, et al. The influence of abcb1 polymorphism ct on the pharmacokinetics of silibinin [J]. J Clin Pharm Ther. Zanger UM, Schwab M. Cytochrome p enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation [J]. Pharmacol Ther. Rendic S. Summary of information on human cyp enzymes: human p metabolism data [J]. Drug Metab Rev. Miniscalco A, Lundahl J, Regårdh C, et al. Inhibition of dihydropyridine metabolism in rat and human liver microsomes by flavonoids found in grapefruit juice [J]. J Pharmacol Exp Ther. Schubert W, Eriksson U, Edgar B, et al. Flavonoids in grapefruit juice inhibit the in vitro hepatic metabolism of 17β-estradiol [J]. Eur J Drug Metab Pharmacokinet. Bailey DG, Dresser G, Arnold JM. Grapefruit-medication interactions: forbidden fruit or avoidable consequences? Dong J, Zhang Q, Cui Q, et al. Flavonoids and naphthoflavonoids: wider roles in the modulation of cytochrome p family 1 enzymes [J]. Arora S, Taneja I, Challagundla M, et al. In vivo prediction of cyp-mediated metabolic interaction potential of formononetin and biochanin a using in vitro human and rat cyp inhibition data [J]. Toxicol Lett. Shimada T, Tanaka K, Takenaka S, et al. Structure—function relationships of inhibition of human cytochromes p 1a1, 1a2, 1b1, 2c9, and 3a4 by 33 flavonoid derivatives [J]. Chem Res Toxicol. Takemura H, Itoh T, Yamamoto K, et al. Selective inhibition of methoxyflavonoids on human cyp1b1 activity [J]. Bioorg Med Chem. Androutsopoulos VP, Papakyriakou A, Vourloumis D, et al. Comparative cyp1a1 and cyp1b1 substrate and inhibitor profile of dietary flavonoids [J]. Sridhar J, Ellis J, Dupart P, et al. Development of flavone propargyl ethers as potent and selective inhibitors of cytochrome p enzymes 1a1 and 1a2 [J]. Drug Metab Lett. Dong H, Lin W, Wu J, et al. Flavonoids activate pregnane × receptor-mediated cyp3a4 gene expression by inhibiting cyclin-dependent kinases in hepg2 liver carcinoma cells [J]. BMC Biochem. Satsu H, Hiura Y, Mochizuki K, et al. Activation of pregnane x receptor and induction of mdr1 by dietary phytochemicals [J]. Li Y, Ross-Viola JS, Shay NF, et al. Human cyp3a4 and murine cyp3a11 are regulated by equol and genistein via the pregnane x receptor in a species-specific manner [J]. Mooiman KD, Maas-Bakker RF, Moret EE, et al. Korobkova EA. Effect of natural polyphenols on cyp metabolism: implications for diseases [J]. Zeng M, Sun R, Basu S, et al. Disposition of flavonoids via recycling: direct biliary excretion of enterically or extrahepatically derived flavonoid glucuronides [J]. Guinane CM, Cotter PD. Role of the gut microbiota in health and chronic gastrointestinal disease: understanding a hidden metabolic organ [J]. Ther Adv Gastroenterol. Lu K, Mahbub R, Fox JG. Xenobiotics: interaction with the intestinal microflora [J]. ILAR J. Nicholson JK, Holmes E, Kinross J, et al. Host-gut microbiota metabolic interactions [J]. Scheline RR. Drug metabolism by intestinal microorganisms [J]. Laparra JM, Sanz Y. Interactions of gut microbiota with functional food components and nutraceuticals [J]. Pharmacol Res. Selma MV, Espin JC, Tomas-Barberan FA. Interaction between phenolics and gut microbiota: role in human health [J]. Lin W, Wang W, Yang H, et al. Influence of intestinal microbiota on the catabolism of flavonoids in mice. J Food Sci. Ozdal T, Sela DA, Xiao J, Boyacioglu D, Chen F, Capanoglu E. The reciprocal interactions between polyphenols and gut microbiota and effects on bioaccessibility. Nurmi T, Mursu J, Heinonen M, et al. Metabolism of berry anthocyanins to phenolic acids in humans [J]. Atkinson C, Berman S, Humbert O, et al. In vitro incubation of human feces with daidzein and antibiotics suggests interindividual differences in the bacteria responsible for equol production [J]. Lampe JW. Interindividual differences in response to plant-based diets: implications for cancer risk [J]. Simons AL, Renouf M, Hendrich S, et al. Human gut microbial degradation of flavonoids: structure-function relationships [J]. Duda-Chodak A. The inhibitory effect of polyphenols on human gut microbiota [J]. J Physiol Pharmacol. Fotschki B, Juskiewicz J, Sojka M, et al. Ellagitannins and flavanols from raspberry pomace modulate caecal fermentation processes and plasma lipid parameters in rats [J]. Esposito D, Damsud T, Wilson M, et al. Black currant anthocyanins attenuate weight gain and improve glucose metabolism in diet-induced obese mice with intact, but not disrupted, gut microbiome [J]. Bridle P, Timberlake CF. Anthocyanins as natural food colours—selected aspects [J]. Pappas EL. Improving stability of color, total phenolics, flavonoids and ascorbic acid in cranberry juice cocktail via alternative processing and storage techniques. New Brunswick: Rutgers University-Graduate School; Ruenroengklin N, Zhong J, Duan X, et al. Effects of various temperatures and ph values on the extraction yield of phenolics from litchi fruit pericarp tissue and the antioxidant activity of the extracted anthocyanins [J]. Int J Mol Sci. Ghasemzadeh A, Jaafar HZ, Rahmat A, et al. Effect of different light intensities on total phenolics and flavonoids synthesis and anti-oxidant activities in young ginger varieties zingiber officinale roscoe [J]. Maini S, Hodgson HL, Krol ES. The uva and aqueous stability of flavonoids is dependent on b-ring substitution [J]. Perez-Jimenez J, Serrano J, Tabernero M, et al. Bioavailability of phenolic antioxidants associated with dietary fiber: plasma antioxidant capacity after acute and long-term intake in humans [J]. Plant Foods Hum Nutr. Palafox-Carlos H, Ayala-Zavala JF, González-Aguilar GA. The role of dietary fiber in the bioaccessibility and bioavailability of fruit and vegetable antioxidants [J]. Saura-Calixto F. Dietary fiber as a carrier of dietary antioxidants: an essential physiological function [J]. Yang L, Cao YL, Jiang JG, et al. Response surface optimization of ultrasound-assisted flavonoids extraction from the flower of citrus aurantium l. Amara engl [J]. J Sep Sci. Liu Y, Wang H, Cai X. Optimization of the extraction of total flavonoids from scutellaria baicalensis georgi using the response surface methodology [J]. J Food Sci Technol. Wang X, Wu Y, Chen G, et al. Optimisation of ultrasound assisted extraction of phenolic compounds from sparganii rhizoma with response surface methodology [J]. Ultrason Sonochem. Arif Khan SER, John ML and Barbara LK. San Francisco: American Institute of Chemical Engineers; Kurepa J, Nakabayashi R, Paunesku T, et al. Direct isolation of flavonoids from plants using ultra-small anatase tio 2 nanoparticles [J]. Plant J. Wang J, Zhao Y-M, Guo C-Y, et al. Ultrasound-assisted extraction of total flavonoids from Inula helenium [J]. Pharmacogn Mag. Zheng L-L, Wang D, Li YY, et al. Ultrasound-assisted extraction of total flavonoids from Aconitum gymnandrum [J]. Wu J, Du G, Zhou J, et al. Systems metabolic engineering of microorganisms to achieve large-scale production of flavonoid scaffolds [J]. J Biotechnol. Santos CN, Koffas M, Stephanopoulos G. Optimization of a heterologous pathway for the production of flavonoids from glucose [J]. Metab Eng. Metabolic engineering of Escherichia coli for 2s -pinocembrin production from glucose by a modular metabolic strategy [J]. Vannelli T, Wei Qi W, Sweigard J, et al. Production of p-hydroxycinnamic acid from glucose in Saccharomyces cerevisiae and Escherichia coli by expression of heterologous genes from plants and fungi [J]. Koopman F, Beekwilder J, Crimi B, et al. De novo production of the flavonoid naringenin in engineered Saccharomyces cerevisiae [J]. Microb Cell Fact. Wang Y, Chen S, Yu O. Metabolic engineering of flavonoids in plants and microorganisms [J]. Appl Microbiol Biotechnol. Thilakarathna SH, Rupasinghe HPV. Flavonoid bioavailability and attempts for bioavailability enhancement [J]. Olthof MR, Hollman PC, Vree TB, et al. VTatiraju D, Bagade VB, JKarambelkar P, et al. Natural bioenhancers: an overview [J]. J Pharmacogn Phytochem. Rinwa P, Kumar A. Quercetin along with piperine prevents cognitive dysfunction, oxidative stress and neuro-inflammation associated with mouse model of chronic unpredictable stress. PubMed Google Scholar. Lambert JD, Hong J, Kim DH, et al. Piperine enhances the bioavailability of the tea polyphenol - -epigallocatechingallate in mice [J]. Shoba G, Joy D, Joseph T, et al. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers [J]. Planta Med. Vaidyanathan JB, Walle T. Cellular uptake and efflux of the tea flavonoid - epicatechingallate in the human intestinal cell line caco-2 [J]. Gao S, Hu M. Bioavailability challenges associated with development of anti-cancer phenolics [J]. Vue B, Zhang S, Zhang X, et al. Silibinin derivatives as anti-prostate cancer agents: synthesis and cell-based evaluations [J]. Eur J Med Chem. Sy-Cordero AA, Graf TN, Runyon SP, et al. Enhanced bioactivity of silybin b methylation products [J]. Džubák P, Hajdúch M, Gažák R, et al. New derivatives of silybin and 2,3-dehydrosilybin and their cytotoxic and p-glycoprotein modulatory activity [J]. Althagafy HS, Graf TN, Sy-Cordero AA, et al. Semisynthesis, cytotoxicity, antiviral activity, and drug interaction liability of 7-o-methylated analogues of flavonolignans from milk thistle [J]. Grande F, Parisi OI, Mordocco RA, et al. Quercetin derivatives as novel antihypertensive agents: synthesis and physiological characterization [J]. Kim MK, Park K-S, Lee C, et al. Enhanced stability and intracellular accumulation of quercetin by protection of the chemically or metabolically susceptible hydroxyl groups with a pivaloxymethyl pom promoiety [J]. J Med Chem. Patra N, De U, Kang J-A, et al. A novel epoxypropoxy flavonoid derivative and topoisomerase ii inhibitor, mhy, induces apoptosis in prostate cancer cells [J]. Kumar P, Sharma G, Kumar R, et al. Promises of a biocompatible nanocarrier in improved brain delivery of quercetin: biochemical, pharmacokinetic and biodistribution evidences [J]. Balakrishnan S, Bhat FA, Raja Singh P, et al. Cell Prolif. Kumar RP, Abraham A. Pvp- coated naringenin nanoparticles for biomedical applications-in vivo toxicological evaluations [J]. Chem-Biol Interact. Chen LC, Chen YC, Su CY, et al. Development and characterization of self-assembling lecithin-based mixed polymeric micelles containing quercetin in cancer treatment and an in vivo pharmacokinetic study [J]. Int J Nanomed. Macedo AS, Quelhas S, Silva AM, et al. Nanoemulsions for delivery of flavonoids: formulation and in vitro release of rutin as model drug [J]. Pharm Dev Technol. Yi T, Liu C, Zhang J, et al. A new drug nanocrystal self-stabilized pickering emulsion for oral delivery of silybin [J]. Zhu Y, Wang M, Zhang Y, et al. In vitro release and bioavailability of silybin from micelle-templated porous calcium phosphate microparticles [J]. AAPS PharmSciTech. Penalva R, Gonzalez-Navarro CJ, Gamazo C, et al. Zein nanoparticles for oral delivery of quercetin: pharmacokinetic studies and preventive anti-inflammatory effects in a mouse model of endotoxemia [J]. Nanomed Nanotechnol Biol Med. Filippi A, Petrussa E, Rajcevic U, et al. Flavonoid interaction with a chitinase from grape berry skin: protein identification and modulation of the enzymatic activity [J]. Tang L, Li S, Bi H, et al. Interaction of cyanidino-glucoside with three proteins [J]. Arroyo-Maya IJ, Campos-Teran J, Hernandez-Arana A, et al. Characterization of flavonoid-protein interactions using fluorescence spectroscopy: binding of pelargonidin to dairy proteins [J]. Kanakis CD, Tarantilis PA, Polissiou MG, et al. Probing the binding sites of resveratrol, genistein, and curcumin with milk beta-lactoglobulin [J]. J Biomol Struct Dyn. He Z, Xu M, Zeng M, et al. Interactions of milk alpha- and beta-casein with malvidino-glucoside and their effects on the stability of grape skin anthocyanin extracts [J]. Devendra S, Mohan SMR, Ajay S, et al. Quercetin-phospholipid complex: an amorphous pharmaceutical system in herbal drug delivery [J]. Curr Drug Discov Technol. Semalty A, Semalty M, Rawat BS, et al. Pharmacosomes: the lipid-based new drug delivery system [J]. Expert Opin Drug Deliv. Zhang K, Zhang M, Liu Z, et al. Development of quercetin-phospholipid complex to improve the bioavailability and protection effects against carbon tetrachloride-induced hepatotoxicity in sd rats [J]. Download references. HA, CRA, and AKT conceptualized the idea. HA and AKT wrote the paper. AKT and CRA proofed and revised the paper. All authors read and approved the final manuscript. We thank Ms. Charisse Montgomery, University of Toledo for critical reading of this manuscript. This work was supported by seed-fund to AKT from Department of Pharmacology and Experimental Therapeutics at UT. Department of Pharmacology and Systems Therapeutics, College of Pharmacy and Pharmaceutical Sciences, University of Toledo, Toledo, OH, , USA. Pharmaceutical Sciences, College of Pharmacy, St. Department of Pharmacology and Experimental Therapeutics, College of Pharmacy and Pharmaceutical Sciences, University of Toledo, Toledo, OH, , USA. You can also search for this author in PubMed Google Scholar. Correspondence to Amit K. Open Access This article is distributed under the terms of the Creative Commons Attribution 4. Reprints and permissions. Amawi, H. Chin J Cancer 36 , 50 Download citation. Received : 03 December Accepted : 30 May Published : 19 June Anyone you share the following link with will be able to read this content:. Sorry, a shareable link is not currently available for this article. Provided by the Springer Nature SharedIt content-sharing initiative. Skip to main content. Search all BMC articles Search. Download PDF. Haneen Amawi 1 , Charles R. Ashby Jr. Tiwari 1 , 3 Chinese Journal of Cancer volume 36 , Article number: 50 Cite this article Accesses Citations 1 Altmetric Metrics details. This article has been updated. Abstract Flavonoids are polyphenols that are found in numerous edible plant species. Background Dietary flavonoids are the most common polyphenols found in fruits, vegetables, flowers, chocolate, tea, wine, and other plant sources [ 1 , 2 , 3 ]. Full size image. Flavonoids in cancer chemoprevention Increasing evidence from both epidemiological and laboratory studies suggests that the dietary intake of flavonoids reduces the risk of developing certain types of cancers [ 10 ]. Challenges in flavonoids in cancer chemoprevention development Despite preclinical evidence suggesting that flavonoids have anticancer and preventive efficacy, there are numerous problems that have impeded the development of dietary flavonoids as approved drugs for clinical use. Improving purification and isolation yields As mentioned earlier, the current traditional isolation and purification techniques usually result in low extraction yield of flavonoids that does not justify the high extraction cost. Overcoming PK challenges There are a number of approaches or strategies that can be used to surmount factors that lower the bioavailability of flavonoids. Conclusions The preclinical anticancer effect of certain flavonoids suggests that the flavonoids may prevent certain types of cancer. Change history 30 August An erratum to this article has been published. References Chahar MK, Sharma N, Dobhal MP, et al. Article CAS PubMed PubMed Central Google Scholar Katyal P, Bhardwaj N, Khajuria R. CAS Google Scholar Harris Z, Donovan MG, Branco GM, Limesand KH, Burd R. Article PubMed PubMed Central Google Scholar Si HY, Li DP, Wang TM, et al. Article CAS PubMed Google Scholar Nema R, Jain P, Khare S, Pradhan A. Google Scholar Hodek P, Trefil P, Stiborova M. Article CAS PubMed Google Scholar Hertog MGL, Hollman PCH, van de Putte B. Article CAS Google Scholar Gontijo VS, Dos Santos MH, Viegas C Jr. Google Scholar Kumar S, Pandey AK. Google Scholar Neuhouser ML. Article CAS PubMed Google Scholar Ohga N, Hida K, Hida Y, et al. Article CAS PubMed Google Scholar Bermudez-Soto MJ, Larrosa M, Garcia-Cantalejo J, et al. Article CAS PubMed PubMed Central Google Scholar Vue B, Zhang S, Chen QH. Article CAS PubMed Google Scholar Wenzel U, Kuntz S, Brendel MD, et al. CAS PubMed Google Scholar Dal-Ho H, Hirofumi T, Yamada K. Google Scholar Yin F, Giuliano AE, Van Herle AJ. CAS PubMed Google Scholar Woo H-H, Jeong BR, Hawes MC. Article CAS Google Scholar Cho HJ, Suh DS, Moon SH, et al. Article CAS PubMed Google Scholar Petrick JL, Steck SE, Bradshaw PT, et al. Article CAS PubMed PubMed Central Google Scholar Cibin TR, Devi DG, Abraham A. CAS PubMed Google Scholar Rossi M, Rosato V, Bosetti C, et al. Article PubMed Google Scholar Surh YJ. Article CAS PubMed Google Scholar Tsyrlov IB, Mikhailenko VM, Gelboin HV. Article CAS PubMed Google Scholar Manthey JA, Grohmann K, Guthrie N. Article CAS PubMed Google Scholar Iwashita K, Kobori M, Yamaki K, et al. Article CAS PubMed Google Scholar Lee WR, Shen SC, Lin HY, et al. Article CAS PubMed Google Scholar Konig A, Schwartz GK, Mohammad RM, et al. CAS PubMed Google Scholar Wang HK. Article CAS PubMed Google Scholar Le Marchand L, Murphy SP, Hankin JH, et al. Article PubMed Google Scholar Sun XY, Plouzek CA, Henry JP, et al. CAS PubMed Google Scholar Bu-Abbas A, Clifford MN, Walker R, et al. Article CAS PubMed Google Scholar Fotsis T, Pepper MS, Aktas E, et al. |
| The Effects and Mechanisms of Flavonoids on Cancer Prevention and Therapy: Focus on Gut Microbiota | New insights on the anticancer properties of dietary polyphenols [J]. Falzone L, Salomone S, Libra M. Propionibacterium acnes overabundance and natural killer group 2 member D system activation in corpus-dominant lymphocytic gastritis. Molecular and cellular basis of the anticancer activity of the prenylated flavonoid icaritin in hepatocellular carcinoma. Compounds from the same category of flavonoids may have diverse effects on the same bacterial strain. Article PubMed Google Scholar Awan FT, Jones JA, Maddocks K, Poi M, Grever MR, Johnson A, et al. |
Flavonoids and cancer prevention -
Mammalian drug efflux transporters of the atp binding cassette abc family in multidrug resistance: a review of the past decade [J]. Cancer Lett. Klappe K, Hummel I, Hoekstra D, et al.
Lipid dependence of abc transporter localization and function [J]. Chem Phys Lipid. Murakami T, Takano M. Intestinal efflux transporters and drug absorption [J].
Expert Opin Drug Metab Toxicol. Russel FG. Transporters: Importance in drug absorption, distribution, and removal [M]. Enzyme-and transporter-based drug-drug interactions.
Book Google Scholar. Alvarez AI, Real R, Pérez M, et al. Modulation of the activity of abc transporters p-glycoprotein, mrp2, bcrp by flavonoids and drug response [J].
J Pharm Sci. Cermak R, Wolffram S. The potential of flavonoids to influence drug metabolism and pharmacokinetics by local gastrointestinal mechanisms [J]. Curr Drug Metab. Gatouillat G, Magid AA, Bertin E, et al. Medicarpin and millepurpan, two flavonoids isolated from medicago sativa, induce apoptosis and overcome multidrug resistance in leukemia p cells [J].
Dash RP, Ellendula B, Agarwal M, et al. Increased intestinal p-glycoprotein expression and activity with progression of diabetes and its modulation by epigallocatechingallate: Evidence from pharmacokinetic studies [J].
Eur J Pharmacol. Wink M, Ashour ML, El-Readi MZ. Secondary metabolites from plants inhibiting abc transporters and reversing resistance of cancer cells and microbes to cytotoxic and antimicrobial agents.
Front Microbiol. Schoonbeek HJ, Raaijmakers JM, De Waard MA. Fungal abc transporters and microbial interactions in natural environments [J]. Mol Plant Microbe Interact. Marzolini C, Paus E, Buclin T, et al. Polymorphisms in human mdr1 p-glycoprotein : recent advances and clinical relevance [J].
Clin Pharmacol Ther. Choi J-S, Han H-K. Enhanced oral exposure of diltiazem by the concomitant use of naringin in rats [J]. Int J Pharm. Ofer M, Wolffram S, Koggel A, et al. Modulation of drug transport by selected flavonoids: involvement of p-gp and oct?
Spahn-Langguth H, Langguth P. Grapefruit juice enhances intestinal absorption of the p-glycoprotein substrate talinolol [J]. Brand W, Schutte ME, Williamson G, et al. Flavonoid-mediated inhibition of intestinal abc transporters may affect the oral bioavailability of drugs, food-borne toxic compounds and bioactive ingredients [J].
Li Y, Paxton JW. The effects of flavonoids on the abc transporters: consequences for the pharmacokinetics of substrate drugs [J]. Schexnayder C, Stratford RE. Genistein and glyceollin effects on abcc2 mrp2 and abcg2 bcrp in caco-2 cells [J].
Int J Environ Res Public Health. Article PubMed Central CAS Google Scholar. Bernardo J, Valentao P, Grosso C, et al. Flavonoids in neurodegeneration: Limitations and strategies to cross cns barriers [J].
Article PubMed CAS Google Scholar. Tan ZR, Zhou YX, Liu J, et al. The influence of abcb1 polymorphism ct on the pharmacokinetics of silibinin [J]. J Clin Pharm Ther. Zanger UM, Schwab M.
Cytochrome p enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation [J]. Pharmacol Ther. Rendic S. Summary of information on human cyp enzymes: human p metabolism data [J].
Drug Metab Rev. Miniscalco A, Lundahl J, Regårdh C, et al. Inhibition of dihydropyridine metabolism in rat and human liver microsomes by flavonoids found in grapefruit juice [J].
J Pharmacol Exp Ther. Schubert W, Eriksson U, Edgar B, et al. Flavonoids in grapefruit juice inhibit the in vitro hepatic metabolism of 17β-estradiol [J]. Eur J Drug Metab Pharmacokinet. Bailey DG, Dresser G, Arnold JM. Grapefruit-medication interactions: forbidden fruit or avoidable consequences?
Dong J, Zhang Q, Cui Q, et al. Flavonoids and naphthoflavonoids: wider roles in the modulation of cytochrome p family 1 enzymes [J].
Arora S, Taneja I, Challagundla M, et al. In vivo prediction of cyp-mediated metabolic interaction potential of formononetin and biochanin a using in vitro human and rat cyp inhibition data [J]. Toxicol Lett. Shimada T, Tanaka K, Takenaka S, et al.
Structure—function relationships of inhibition of human cytochromes p 1a1, 1a2, 1b1, 2c9, and 3a4 by 33 flavonoid derivatives [J]. Chem Res Toxicol. Takemura H, Itoh T, Yamamoto K, et al. Selective inhibition of methoxyflavonoids on human cyp1b1 activity [J].
Bioorg Med Chem. Androutsopoulos VP, Papakyriakou A, Vourloumis D, et al. Comparative cyp1a1 and cyp1b1 substrate and inhibitor profile of dietary flavonoids [J].
Sridhar J, Ellis J, Dupart P, et al. Development of flavone propargyl ethers as potent and selective inhibitors of cytochrome p enzymes 1a1 and 1a2 [J]. Drug Metab Lett. Dong H, Lin W, Wu J, et al. Flavonoids activate pregnane × receptor-mediated cyp3a4 gene expression by inhibiting cyclin-dependent kinases in hepg2 liver carcinoma cells [J].
BMC Biochem. Satsu H, Hiura Y, Mochizuki K, et al. Activation of pregnane x receptor and induction of mdr1 by dietary phytochemicals [J]. Li Y, Ross-Viola JS, Shay NF, et al. Human cyp3a4 and murine cyp3a11 are regulated by equol and genistein via the pregnane x receptor in a species-specific manner [J].
Mooiman KD, Maas-Bakker RF, Moret EE, et al. Korobkova EA. Effect of natural polyphenols on cyp metabolism: implications for diseases [J].
Zeng M, Sun R, Basu S, et al. Disposition of flavonoids via recycling: direct biliary excretion of enterically or extrahepatically derived flavonoid glucuronides [J]. Guinane CM, Cotter PD. Role of the gut microbiota in health and chronic gastrointestinal disease: understanding a hidden metabolic organ [J].
Ther Adv Gastroenterol. Lu K, Mahbub R, Fox JG. Xenobiotics: interaction with the intestinal microflora [J]. ILAR J. Nicholson JK, Holmes E, Kinross J, et al. Host-gut microbiota metabolic interactions [J].
Scheline RR. Drug metabolism by intestinal microorganisms [J]. Laparra JM, Sanz Y. Interactions of gut microbiota with functional food components and nutraceuticals [J]. Pharmacol Res. Selma MV, Espin JC, Tomas-Barberan FA. Interaction between phenolics and gut microbiota: role in human health [J].
Lin W, Wang W, Yang H, et al. Influence of intestinal microbiota on the catabolism of flavonoids in mice. J Food Sci. Ozdal T, Sela DA, Xiao J, Boyacioglu D, Chen F, Capanoglu E. The reciprocal interactions between polyphenols and gut microbiota and effects on bioaccessibility.
Nurmi T, Mursu J, Heinonen M, et al. Metabolism of berry anthocyanins to phenolic acids in humans [J]. Atkinson C, Berman S, Humbert O, et al. In vitro incubation of human feces with daidzein and antibiotics suggests interindividual differences in the bacteria responsible for equol production [J].
Lampe JW. Interindividual differences in response to plant-based diets: implications for cancer risk [J]. Simons AL, Renouf M, Hendrich S, et al. Human gut microbial degradation of flavonoids: structure-function relationships [J].
Duda-Chodak A. The inhibitory effect of polyphenols on human gut microbiota [J]. J Physiol Pharmacol. Fotschki B, Juskiewicz J, Sojka M, et al.
Ellagitannins and flavanols from raspberry pomace modulate caecal fermentation processes and plasma lipid parameters in rats [J]. Esposito D, Damsud T, Wilson M, et al. Black currant anthocyanins attenuate weight gain and improve glucose metabolism in diet-induced obese mice with intact, but not disrupted, gut microbiome [J].
Bridle P, Timberlake CF. Anthocyanins as natural food colours—selected aspects [J]. Pappas EL. Improving stability of color, total phenolics, flavonoids and ascorbic acid in cranberry juice cocktail via alternative processing and storage techniques.
New Brunswick: Rutgers University-Graduate School; Ruenroengklin N, Zhong J, Duan X, et al. Effects of various temperatures and ph values on the extraction yield of phenolics from litchi fruit pericarp tissue and the antioxidant activity of the extracted anthocyanins [J].
Int J Mol Sci. Ghasemzadeh A, Jaafar HZ, Rahmat A, et al. Effect of different light intensities on total phenolics and flavonoids synthesis and anti-oxidant activities in young ginger varieties zingiber officinale roscoe [J]. Maini S, Hodgson HL, Krol ES.
The uva and aqueous stability of flavonoids is dependent on b-ring substitution [J]. Perez-Jimenez J, Serrano J, Tabernero M, et al. Bioavailability of phenolic antioxidants associated with dietary fiber: plasma antioxidant capacity after acute and long-term intake in humans [J]. Plant Foods Hum Nutr.
Palafox-Carlos H, Ayala-Zavala JF, González-Aguilar GA. The role of dietary fiber in the bioaccessibility and bioavailability of fruit and vegetable antioxidants [J].
Saura-Calixto F. Dietary fiber as a carrier of dietary antioxidants: an essential physiological function [J]. Yang L, Cao YL, Jiang JG, et al. Response surface optimization of ultrasound-assisted flavonoids extraction from the flower of citrus aurantium l.
Amara engl [J]. J Sep Sci. Liu Y, Wang H, Cai X. Optimization of the extraction of total flavonoids from scutellaria baicalensis georgi using the response surface methodology [J].
J Food Sci Technol. Wang X, Wu Y, Chen G, et al. Optimisation of ultrasound assisted extraction of phenolic compounds from sparganii rhizoma with response surface methodology [J].
Ultrason Sonochem. Arif Khan SER, John ML and Barbara LK. San Francisco: American Institute of Chemical Engineers; Kurepa J, Nakabayashi R, Paunesku T, et al. Direct isolation of flavonoids from plants using ultra-small anatase tio 2 nanoparticles [J]. Plant J. Wang J, Zhao Y-M, Guo C-Y, et al.
Ultrasound-assisted extraction of total flavonoids from Inula helenium [J]. Pharmacogn Mag. Zheng L-L, Wang D, Li YY, et al. Ultrasound-assisted extraction of total flavonoids from Aconitum gymnandrum [J]. Wu J, Du G, Zhou J, et al. Systems metabolic engineering of microorganisms to achieve large-scale production of flavonoid scaffolds [J].
J Biotechnol. Santos CN, Koffas M, Stephanopoulos G. Optimization of a heterologous pathway for the production of flavonoids from glucose [J]. Metab Eng. Metabolic engineering of Escherichia coli for 2s -pinocembrin production from glucose by a modular metabolic strategy [J].
Vannelli T, Wei Qi W, Sweigard J, et al. Production of p-hydroxycinnamic acid from glucose in Saccharomyces cerevisiae and Escherichia coli by expression of heterologous genes from plants and fungi [J].
Koopman F, Beekwilder J, Crimi B, et al. De novo production of the flavonoid naringenin in engineered Saccharomyces cerevisiae [J].
Microb Cell Fact. Wang Y, Chen S, Yu O. Metabolic engineering of flavonoids in plants and microorganisms [J]. Appl Microbiol Biotechnol. Thilakarathna SH, Rupasinghe HPV. Flavonoid bioavailability and attempts for bioavailability enhancement [J].
Olthof MR, Hollman PC, Vree TB, et al. VTatiraju D, Bagade VB, JKarambelkar P, et al. Natural bioenhancers: an overview [J]. J Pharmacogn Phytochem. Rinwa P, Kumar A. Quercetin along with piperine prevents cognitive dysfunction, oxidative stress and neuro-inflammation associated with mouse model of chronic unpredictable stress.
PubMed Google Scholar. Lambert JD, Hong J, Kim DH, et al. Piperine enhances the bioavailability of the tea polyphenol - -epigallocatechingallate in mice [J]. Shoba G, Joy D, Joseph T, et al. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers [J].
Planta Med. Vaidyanathan JB, Walle T. Cellular uptake and efflux of the tea flavonoid - epicatechingallate in the human intestinal cell line caco-2 [J].
Gao S, Hu M. Bioavailability challenges associated with development of anti-cancer phenolics [J]. Vue B, Zhang S, Zhang X, et al. Silibinin derivatives as anti-prostate cancer agents: synthesis and cell-based evaluations [J].
Eur J Med Chem. Sy-Cordero AA, Graf TN, Runyon SP, et al. Enhanced bioactivity of silybin b methylation products [J]. Džubák P, Hajdúch M, Gažák R, et al. New derivatives of silybin and 2,3-dehydrosilybin and their cytotoxic and p-glycoprotein modulatory activity [J].
Althagafy HS, Graf TN, Sy-Cordero AA, et al. Semisynthesis, cytotoxicity, antiviral activity, and drug interaction liability of 7-o-methylated analogues of flavonolignans from milk thistle [J]. Grande F, Parisi OI, Mordocco RA, et al.
Quercetin derivatives as novel antihypertensive agents: synthesis and physiological characterization [J]. Kim MK, Park K-S, Lee C, et al. Enhanced stability and intracellular accumulation of quercetin by protection of the chemically or metabolically susceptible hydroxyl groups with a pivaloxymethyl pom promoiety [J].
J Med Chem. Patra N, De U, Kang J-A, et al. A novel epoxypropoxy flavonoid derivative and topoisomerase ii inhibitor, mhy, induces apoptosis in prostate cancer cells [J].
Kumar P, Sharma G, Kumar R, et al. Promises of a biocompatible nanocarrier in improved brain delivery of quercetin: biochemical, pharmacokinetic and biodistribution evidences [J].
Balakrishnan S, Bhat FA, Raja Singh P, et al. Cell Prolif. Kumar RP, Abraham A. Pvp- coated naringenin nanoparticles for biomedical applications-in vivo toxicological evaluations [J].
Chem-Biol Interact. Chen LC, Chen YC, Su CY, et al. Development and characterization of self-assembling lecithin-based mixed polymeric micelles containing quercetin in cancer treatment and an in vivo pharmacokinetic study [J]. Int J Nanomed. Macedo AS, Quelhas S, Silva AM, et al.
Nanoemulsions for delivery of flavonoids: formulation and in vitro release of rutin as model drug [J]. Pharm Dev Technol. Yi T, Liu C, Zhang J, et al.
A new drug nanocrystal self-stabilized pickering emulsion for oral delivery of silybin [J]. Zhu Y, Wang M, Zhang Y, et al. In vitro release and bioavailability of silybin from micelle-templated porous calcium phosphate microparticles [J].
AAPS PharmSciTech. Penalva R, Gonzalez-Navarro CJ, Gamazo C, et al. Zein nanoparticles for oral delivery of quercetin: pharmacokinetic studies and preventive anti-inflammatory effects in a mouse model of endotoxemia [J]. Nanomed Nanotechnol Biol Med. Filippi A, Petrussa E, Rajcevic U, et al.
Flavonoid interaction with a chitinase from grape berry skin: protein identification and modulation of the enzymatic activity [J].
Tang L, Li S, Bi H, et al. Interaction of cyanidino-glucoside with three proteins [J]. Arroyo-Maya IJ, Campos-Teran J, Hernandez-Arana A, et al.
Characterization of flavonoid-protein interactions using fluorescence spectroscopy: binding of pelargonidin to dairy proteins [J].
Kanakis CD, Tarantilis PA, Polissiou MG, et al. Probing the binding sites of resveratrol, genistein, and curcumin with milk beta-lactoglobulin [J]. J Biomol Struct Dyn.
He Z, Xu M, Zeng M, et al. Interactions of milk alpha- and beta-casein with malvidino-glucoside and their effects on the stability of grape skin anthocyanin extracts [J]. Devendra S, Mohan SMR, Ajay S, et al.
Quercetin-phospholipid complex: an amorphous pharmaceutical system in herbal drug delivery [J]. Curr Drug Discov Technol. Semalty A, Semalty M, Rawat BS, et al.
Pharmacosomes: the lipid-based new drug delivery system [J]. Expert Opin Drug Deliv. Zhang K, Zhang M, Liu Z, et al. Development of quercetin-phospholipid complex to improve the bioavailability and protection effects against carbon tetrachloride-induced hepatotoxicity in sd rats [J].
Download references. HA, CRA, and AKT conceptualized the idea. HA and AKT wrote the paper. AKT and CRA proofed and revised the paper.
All authors read and approved the final manuscript. We thank Ms. Charisse Montgomery, University of Toledo for critical reading of this manuscript. This work was supported by seed-fund to AKT from Department of Pharmacology and Experimental Therapeutics at UT.
Department of Pharmacology and Systems Therapeutics, College of Pharmacy and Pharmaceutical Sciences, University of Toledo, Toledo, OH, , USA. Pharmaceutical Sciences, College of Pharmacy, St. Department of Pharmacology and Experimental Therapeutics, College of Pharmacy and Pharmaceutical Sciences, University of Toledo, Toledo, OH, , USA.
You can also search for this author in PubMed Google Scholar. Correspondence to Amit K. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.
Reprints and permissions. Amawi, H. Chin J Cancer 36 , 50 Download citation. Received : 03 December Accepted : 30 May Published : 19 June Anyone you share the following link with will be able to read this content:.
Sorry, a shareable link is not currently available for this article. Provided by the Springer Nature SharedIt content-sharing initiative.
Skip to main content. Search all BMC articles Search. Download PDF. Haneen Amawi 1 , Charles R. Ashby Jr. Tiwari 1 , 3 Chinese Journal of Cancer volume 36 , Article number: 50 Cite this article Accesses Citations 1 Altmetric Metrics details.
This article has been updated. Abstract Flavonoids are polyphenols that are found in numerous edible plant species. Background Dietary flavonoids are the most common polyphenols found in fruits, vegetables, flowers, chocolate, tea, wine, and other plant sources [ 1 , 2 , 3 ]. Full size image.
Flavonoids in cancer chemoprevention Increasing evidence from both epidemiological and laboratory studies suggests that the dietary intake of flavonoids reduces the risk of developing certain types of cancers [ 10 ].
Challenges in flavonoids in cancer chemoprevention development Despite preclinical evidence suggesting that flavonoids have anticancer and preventive efficacy, there are numerous problems that have impeded the development of dietary flavonoids as approved drugs for clinical use.
Improving purification and isolation yields As mentioned earlier, the current traditional isolation and purification techniques usually result in low extraction yield of flavonoids that does not justify the high extraction cost.
Overcoming PK challenges There are a number of approaches or strategies that can be used to surmount factors that lower the bioavailability of flavonoids.
Conclusions The preclinical anticancer effect of certain flavonoids suggests that the flavonoids may prevent certain types of cancer.
Change history 30 August An erratum to this article has been published. References Chahar MK, Sharma N, Dobhal MP, et al. Article CAS PubMed PubMed Central Google Scholar Katyal P, Bhardwaj N, Khajuria R. CAS Google Scholar Harris Z, Donovan MG, Branco GM, Limesand KH, Burd R. Article PubMed PubMed Central Google Scholar Si HY, Li DP, Wang TM, et al.
Article CAS PubMed Google Scholar Nema R, Jain P, Khare S, Pradhan A. Google Scholar Hodek P, Trefil P, Stiborova M. Article CAS PubMed Google Scholar Hertog MGL, Hollman PCH, van de Putte B. Article CAS Google Scholar Gontijo VS, Dos Santos MH, Viegas C Jr. Google Scholar Kumar S, Pandey AK.
Google Scholar Neuhouser ML. Article CAS PubMed Google Scholar Ohga N, Hida K, Hida Y, et al. Article CAS PubMed Google Scholar Bermudez-Soto MJ, Larrosa M, Garcia-Cantalejo J, et al.
Article CAS PubMed PubMed Central Google Scholar Vue B, Zhang S, Chen QH. Article CAS PubMed Google Scholar Wenzel U, Kuntz S, Brendel MD, et al. CAS PubMed Google Scholar Dal-Ho H, Hirofumi T, Yamada K.
Google Scholar Yin F, Giuliano AE, Van Herle AJ. CAS PubMed Google Scholar Woo H-H, Jeong BR, Hawes MC. Article CAS Google Scholar Cho HJ, Suh DS, Moon SH, et al. Article CAS PubMed Google Scholar Petrick JL, Steck SE, Bradshaw PT, et al.
Article CAS PubMed PubMed Central Google Scholar Cibin TR, Devi DG, Abraham A. CAS PubMed Google Scholar Rossi M, Rosato V, Bosetti C, et al. Article PubMed Google Scholar Surh YJ. Article CAS PubMed Google Scholar Tsyrlov IB, Mikhailenko VM, Gelboin HV.
Article CAS PubMed Google Scholar Manthey JA, Grohmann K, Guthrie N. Article CAS PubMed Google Scholar Iwashita K, Kobori M, Yamaki K, et al. Article CAS PubMed Google Scholar Lee WR, Shen SC, Lin HY, et al. Article CAS PubMed Google Scholar Konig A, Schwartz GK, Mohammad RM, et al.
CAS PubMed Google Scholar Wang HK. Article CAS PubMed Google Scholar Le Marchand L, Murphy SP, Hankin JH, et al. Article PubMed Google Scholar Sun XY, Plouzek CA, Henry JP, et al. CAS PubMed Google Scholar Bu-Abbas A, Clifford MN, Walker R, et al.
Article CAS PubMed Google Scholar Fotsis T, Pepper MS, Aktas E, et al. CAS PubMed Google Scholar Kim MH. Article CAS PubMed Google Scholar Schindler R, Mentlein R.
CAS PubMed Google Scholar Kioka N, Hosokawa N, Komano T, et al. J Nutr 9 — Arnold RS, He J, Remo A, Ritsick D, Yin-Goen Q, Lambeth JD, Datta MW, Young AN, Petros JA Nox1 expression determines cellular reactive oxygen and modulates c-fos induced growth factor, interleukin-8, and Cav Am J Pathol 6 — Arts ICW A review of the epidemiological evidence on tea, flavonoids, and lung cancer.
J Nutr S—S. Arts IC, Hollman PC Polyphenols and disease risk in epidemiologic studies. Am J Clin Nutr S—S. Cancer Causes Control — Atkinson C, Warren RML, Sala E, Dowsett M, Dunning AM, Healey CS, Runswick S, Day NE, Bingham SA Red clover-derived isoflavones and mammographic breast density: a double-blind, randomized, placebo-controlled trial.
Breast Cancer Res 6:R—R Atmani D, Chaher N, Atmani D, Berboucha M, Debbache N, Boudaoud H Flavonoids in human health: from structure to biological activity. Curr Nutr Food Sci — Cancer Res — Balasuriya BWN, Rupasinghe HPV Plant flavonoids as angiotensin converting enzyme inhibitors in regulation of hypertension.
Funct Foods Health Dis — Mol Pharmacol — Barnes S Phytoestrogens and breast cancer. Ballieres Clin Endocrinol Metab — Bazzano LA, He J, Ogden LG, Loria CM, Vupputuri S, Myers L, Whelton PK Fruit and vegetable intake and risk of cardiovascular disease in US adults: the first National Health and Nutrition Examination Survey Epidemiologic Follow-up Study.
A J Clin Nutr 76 1 — Bazzoli DL, Hill S, DiSilvestro RA Soy protein antioxidant actions in active, young adult women. Nutr Res — Birt DF, Hendrich S, Wang W Dietary agents in cancer prevention: flavonoids and isoflavonoids.
Pharmacol Ther — Blagosklonny MV Treatment with inhibitors of caspases, that are substrates of drug transporters, selectively permits chemotherapy-induced apoptosis in multidrug-resistant cells but protects normal cells.
Leukemia — Bobe G Flavonoid intake and risk of pancreatic cancer in male smokers Finland. Cancer Epidemiol Biomarkers Prev — Boccardo F, Lunardi G, Guglielmini P, Parodi M, Murialdo R, Schettini G, Rubagotti A Serum enterolactone levels and the risk of breast cancer in women with palpable cysts.
Eur J Cancer 40 1 — Bode AM, Dong Z Post-translational modification of p53 in tumorigenesis. Nat Rev Cancer — Bosetti C, Rossi M, McLaughlin JK, Negri E, Talamini R, Lagiou P, Montella M, Ramazzotti V, Franceshi S, LaVecchia C Flavonoids and the risk of renal cell carcinoma.
Cancer Epidemiol Biomarkers Prev 16 1 — Brand W, Schutte ME, Williamson G, van Zanden JJ, Cnubben NH, Groten JP, van Bladeren PJ, Rietjens IM Flavonoid-mediated inhibition of intestinal ABC transporters may affect the oral bioavailability of drugs, food-borne toxic compounds and bioactive ingredients.
Biomed Pharmacother — Bridges AJ Chemical inhibitors of protein kinases. Chem Rev — Brown AK, Papaemmanouil A, Bhowruth V, Bhatt A, Dover LG, Besra GS Flavonoid inhibitors as novel antimycobacterial agents targeting Rv, a putative dehydratase enzyme involved in Mycobacterium tuberculosis fatty acid synthase II.
Microbiology — Brueggemeier RW, Gu X, Mobley JA, Joomprabutra S, Bhat AS, Whetstone JL Effects of phytoestrogens and synthetic combinatorial libraries on aromatase, estrogen biosynthesis, and metabolism. Ann N Y Acad Sci — Caltagirone S, Rossi C, Poggi A, Ranalletti FO, Natali PG, Brunetti M, Aiello FB, Piantelli M Flavonoids apigenin and quercetin inhibit melanoma growth and metastatic potential.
Int J Cancer — Carr AM Cell cycle: piecing together the p53 puzzle. Science — Casagrande F, Darbon JM Effects of structurally related flavonoids on cell cycle progression of human melanoma cells: regulation of cyclin-dependent kinases CDK2 and CDK1. Biochem Pharmacol — Cermak R Effect of dietary flavonoids on pathways involved in drug metabolism.
Expert Opin Drug Metab Toxicol — Cermak R, Landgraf S, Wolffram S Quercetin glucosides inhibit glucose uptake into brush-border-membrane vesicles of porcine jejunum. Br J Nutr — Chahar MK, Sharma N, Dobhal MP, Joshi YC Flavonoids: a versatile source of anticancer drugs.
Phcog Rev — Chiu FL, Lin JK Downregulation of androgen receptor expression by luteolin causes inhibition of cell proliferation and induction of apoptosis in human prostate cancer cells and xenografts.
Prostate — Ciolino HP, Daschner PJ, Yeh GC Dietary flavonoids quercetin and kaempferol are ligands of aryl hydrocarbon receptor that affect CYP1A1 differentially. Biochem J — Clifford MN Diet-derived phenols in plasma and tissues and their implications for health.
Planta Med — Clifford MN, Brown JE Dietary flavonoids and health—broadening the perspective. In: Andersen ØM, Markham KR eds Flavonoids: chemistry, biochemistry and application, pp — Conseil G, Baubichon-Cortay H, Dayan G, Jault JM, Barron D Flavonoids: a class of modulators with bifunctional interactions at ATP- and steroid-binding sites on mouse P-glycoprotein.
Cotroneo MS, Wang J, Fritz WA, Eltoum IE, Lamartiniere CA Genistein action in the prepubertal mammary gland in a chemoprevention model. Carcinogenesis — Dai Q, Franke AA, Jin F, Shu XO, Hebert JR, Custer LJ, Cheng J, Gao YT, Zheng W Urinary excretion of phytoestrogens and risk of breast cancer among Chinese women in Shanghai.
Dangles O, Dufour C Flavonoids—protein interactions. In: Andersen ØM, Markham KR eds Flavonoids chemistry, biochemistry and applications. CRC Press, pp — Das DK Naturally occurring flavonoids: structure, chemistry, and high performance liquid chromatography methods for separation and characterization.
Methods Enzymol — De Santi C, Pietrabissa A, Mosca F, Rane A, Pacifici GM Inhibition of phenol sulfotransferase SULT1A1 by quercetin in human adult and foetal livers.
Xenobiotica — den Tonkelaar I, Keinan-Boker L, Veer PV, Arts CJ, Adlercreutz H, Thijssen JH, Peeters PH Urinary phytoestrogens and postmenopausal breast cancer risk.
Cancer Epidemiol Biomarkers Prev 10 3 — Dhar DN The chemistry of chalcones and related compounds. Wiley, New York.
DiPietro A, Conseil G, Perez-Victoria JM, Dayan G, Baubichon-Cortaya H, Trompiera D, Steinfels E, Jault JM, de Wet H, Maitrejan M, Comte G, Boumendjel A, Mariotte AM, Dumontet C, McIntosh DB, Goffeau A, Castanys S, Gamarro F, Barron D Modulation by flavonoids of cell multidrug resistance mediated by P-glycoprotein and related ABC transporters.
Cell Mol Life Sci — Djuric Z, Chen G, Doerge DR, Heilbrun LK, Kucuk O Effect of soy isoflavone supplementation on markers of oxidative stress in men and women. Cancer Lett —6. Doostdar H, Burke MD, Mayer RT Bioflavonoids: selective substrates and inhibitors for cytochromes P CYP1A and CYP1B1.
Toxicology — Fang SC, Hsu CL, Lin HT, Yen GC Anticancer effects of flavonoid derivatives isolated from Millettia reticulata Benth in SK-Hep-1 human hepatocellular carcinoma cells.
J Agric Food Chem 58 2 — Favot L, Martin S, Keravis T, Andriantsitohaina R, Lugnier C Involvement of cyclin-dependent pathway in the inhibitory effect of delphinidin on angiogenesis.
Cardiovasc Res — Ferguson PJ, Kurowska E, Freeman DJ, Chambers AF, Koropatnic DJ A flavonoid fraction from cranberrry extract inhibits proliferation of human tumor cell lines. J Nutr 6 — Ferreira JFS, Luthria DL, Sasaki T, Heyerick A Flavonoids from Artemisia annua L. as antioxidants and their potential synergism with artimisin against malaria and cancer.
Molecules — Firestone GL, Sundar SN Anticancer activities of artemisinin and its bioactive derivatives. Expert Rev Mol Med — Foti P, Erba D, Riso P, Spadafranca A, Criscuoli F, Testolin G Comparison between daidzein and genistein antioxidant activity in primary and cancer lymphocytes.
Arch Biochem Biophys — Fotsis T, Pepper M, Adlercreutz H, Fleischmann G, Hase T, Montesano R, Schweigerer L Genistein, a dietary-derived inhibitor of in vitro angiogenesis. Fotsis T, Pepper M, Adlercreutz H, Hase T, Montesano R, Schweigerer L Genistein, a dietary ingested isoflavonoid, inhibits cell proliferation and in vitro angiogenesis.
Fotsis T, Pepper MS, Aktas E, Breit S, Rasku S, Adlercreutz H, Wähälä K, Montesano R, Schweigerer L Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis. BMJ — Fukuyama M, Rokutan K, Sano T, Miyake H, Shimada M, Tashiro S Overexpression of a novel superoxide producing enzyme, NADPH oxidase 1, in adenoma and well differentiated adenocarcinoma of the human colon.
Cancer Lett 1 — Galijatovic A, Otake Y, Walle UK, Walle T Induction of UDP-glucuronosyltransferase UGT1A1 by the flavonoid chrysin in Caco-2 cells: potential role in carcinogen bioinactivation. Pharm Res — Gamet-Payrastre L, Manenti S, Gratacap MP, Tulliez J, Chap H, Payrastre B Flavonoids and the inhibition of PKC and PI 3-kinase.
Gen Pharmacol — Garcia-Closas R, Gonzalez CA, Agudo A, Riboli E Intake of specific carotenoids and flavonoids and the risk of gastric cancer in Spain. Gibellini L, Pinti M, Nasi M, Montagna JP, De Biasi S, Roat E, Bertoncelli L, Cooper EL, Cossarizza A Quercetin and cancer chemoprevention. Evid Based Complement Alternat Med Giuliani C, Noguchi Y, Harii N, Napolitano G, Tatone D, Bucci I, Piantelli M, Monaco F, Kohn LD The flavonoid quercetin regulates growth and gene expression in rat FRTL-5 thyroid cells.
Endocrinology 1 — Goetzl MA, VanVeldhuizen PJ, Thrasher JB Effect of soy phytoestrogens on the prostate. Prostate Cancer Prostatic Dis — Gould KS, Lister C Flavonoid functions in plants.
In: Andersen OM, Markham KR eds Flavonoids chemistry, biochemistry and applications. Griffiths LA, Barrow A The fate of orally and parenterally administered flavonoids in the mammal.
The significance of biliary excretion. Angiologica — Guo JY, Li X, Browning JD Jr, Rottinghaus GE, Lubahn DB, Constantinou A, Bennink M, MacDonald RS Dietary soy isoflavones and estrone protect ovariectomized ERalphaKO and wild-type mice from carcinogen-induced colon cancer. J Nutr — Hackett AM The metabolism of flavonoid compounds in mammals.
In: Cody V, Middleton E Jr, Harborne JB eds Plant flavonoids in biology and medicine: biochemical, pharmacological, and structure—activity relationships.
Alan R Liss lnc, New York, pp — Haddad AQ The cellular and molecular properties of flavonoids in prostate cancer chemoprevention. D Thesis, Institute of Medical Science, University of Toronto.
Harborne JB ed The flavonoids: advances in research since Harborne JB, Williams CA Advances in flavonoid research since Phytochemistry 55 6 — Haslam E Natural polyphenols vegetable tannins as drugs: possible modes of action.
J Nat Prod — Hassan S, Mathesius U The role of flavonoids in root—rhizosphere signalling: opportunities and challenges for improving plant—microbe interactions. J Exp Bot 63 9 — Hastak K, Gupta S, Ahmad N, Agarwal MK, Agarwal ML, Mukhtar H Role of p53 and NF-kappaB in epigallocatechingallateinduced apoptosis of LNCaP cells.
Oncogene — Havsteen BH The biochemistry and medical significance of flavonoids. Cancer Sci 1 — Heinonen M, Rein D, Teresa Satué-Gracia M, Huang S-W, BruceGerman J, Frankel EN Effect of protein on the antioxidant activity of phenolic compounds in a lecithin—liposome oxidation system.
J Agric Food Chem — Heller W, Forkmann G Biosynthesis. In: Harborne JB ed The flavonoids. Advances in research since Chapman and Hall Ltd, London, pp — Hertog MGL, Hollman PCH, Katan MB Content of potentially anticinogenic flavonoids of 28 vegetables and 9 fruits commonly consumed in the Netherlands.
Hertog MGL, Hollman PCH, van de Putte B a Content of potentially anticarcinogenic flavonoids of tea infusions, wines, and fruit juices.
Hertog MGL, Hollman PCH, Katan MB, Kromhout D b Intake of potentially anticarcinogenic flavonoids and their determinants in adults in the Netherlands.
Nutr Cancer — Ho JS, Ma W, Mao DY, Benchimol S pdependent transcriptional repression of c-myc is required for G1 cell cycle arrest.
Mol Cell Biol — Hodek P, Trefil P, Stiborova M Flavonoids: potent and versatile biologically active compounds interacting with cytochromes P Chem Biol Interact 1 :1— Hodek P, Tepla M, Krizkova J, Sulc M, Stiborova M Modulation of cytochrome P enzyme system by selected flavonoids.
Neuro Endocrinol Lett 30 1 — Royal Society of Chemistry, Cambridge. Hollman PCH Absorption, bioavailability, and metabolism of flavonoids.
Pharm Biol 42 S — Hollman PCH, Katan MB Absorption, metabolism, and bioavailability of flavonoids. In: Rice-Evans CA, Paker L eds Flavonoids in health and disease.
Marcel Dekker Inc, New York, pp — Hollman PCH, Katan MB Dietary flavonoids: intake, health effects and bioavailability. Food Chem Toxicol Holzbeierlein JM, McIntosh J, Thrasher JB The role of soy phytoestrogens in prostate cancer.
Curr Opin Urol — Ingram D, Sanders K, Kolybaba M, Lopez D Case control study of phyto-oestrogens and breast cancer. Lancet — Johnson IT New approaches to the role of diet in the prevention of cancers of the alimentary tract. Mutat Res 1—2 :9— Johnson DW, Berg JN, Baldwin MA et al Mutations in the activin receptor-like kinase I gene in hereditary haemorrhagic telangiectasia type 2.
Nat Genet — Johnson J, Maher P, Hanneken A The flavonoid, eriodictyol, induces long-term protection in ARPE cells through its effects on Nrf2 activation and phase II gene expression. Invest Ophthalmol Vis Sci 50 5 — Joussen AM, Rohrschneider K, Reichling J, Kirchhof B, Kruse FE Treatment of corneal neovascularization with dietary isoflavonoids and flavonoids.
Exp Eye Res 71 5 — Ju W, Wang X, Shi H, Chen W, Belinsky SA, Lin Y A critical role of luteolin-induced reactive oxygen species in blockage of tumor necrosis factor-activated nuclear factor kappa B pathway and sensitization of apoptosis in lung cancer cells.
Kameshwaran S, Suresh V, Arunachalam G, Kanthlal SK, Mohanraj M In vitro and in vivo anticancer activity of methanolic flower extract of Tecoma stans flower.
Int Res J Pharm 3 3 — Kang ZC, Tsai SJ, Lee H Quercetin inhibits benzo[a]pyrene-induced DNA adducts in human Hep G2 cells by altering cytochrome P 1A1 expression.
Kilkkinen A, Virtamo J, Vartiainen E, Sankila R, Virtanen MJ, Adlercreutz H, Pietinen P Serum enterolactone concentration is not associated with breast cancer risk in a nested case—control study. Int J Cancer 2 — J Cell Biochem 89 3 — Kim H, Peterson TG, Barnes S Mechanisms of action of the soy isoflavone genistein: emerging role of its effects through transforming growth factor beta signaling pathways.
Kim YJ et al Superoxide anion scavenging and xanthine oxidase inhibition of þ -catechin—aldehyde polycondensates. Amplification of the antioxidant property of þ -catechin by polycondensation with aldehydes.
Biomacromolecules Kim JH, Kang JW, Kim MS, Bak Y, Park YS, Jung KY, Lim YH, Yoon DY The apoptotic effects of the flavonoid N in human cervical cancer cells.
Toxicol In Vitro 26 1 — Kioka M, Hosokawa N, Komano T, Hirayoshi K, Nagata K, Ueda K Quercetin, a bioflavonoid, inhibits the increase of human multidrug resistance gene MDR1 expression caused by arsenite. FEBS Lett — Knekt P, Jarvinen R, Reunanen A, Maatela J Flavonoid intake and coronary mortality in Finland: a cohort study.
Br Med J — Knekt P, Kumpulainen J, Jarvinen R, Rissanen H, Heliovaara M, Reunanen A, Hakulinen T, Aromaa A Flavonoid intake and risk of chronic diseases. Am J Clin Nutr — Kroon PA, Clifford MN, Crozier A, Day AJ, Donovan JL, Manach C, Williamson G How should we assess the effects of exposure to dietary polyphenols in vitro?
Kruse FE, Joussen AM, Fotsis T et al Inhibition of neovacularization of the eye by dietary factors exemplified by isoflavonoids. Ophthalmologie — Kuiper GGJM, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S, Gustafsson JA Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors a and b.
Endocrinology — Kuiper GGJM, Lemmen JG, Carlsson BO, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor b. Kumar PS, Sucheta S, Deepa VS, Selavamani P, Latha S Antioxidant activity in some selected Indian medicinal plants.
African J Biotechnol 7 12 — Kurisawa M, Chung JE, Kim YJ, Uyama H, Kobayashi S Amplification of antioxidant activity and xanthine oxidase inhibition of catechin by enzymatic polymerization.
Biomacromolecules — Lagiou P, Rossi M, Lagiou A, Tzonou A, La Vecchia C, Trichopoulos D Flavonoid intake and liver cancer: a case—control study in Greece. Cancer Causes Control 19 8 — Lai H, Sasaki T, Singh NP, Messay A Effects of artemisinin-tagged holotrasferrin on cancer cells.
Life Sci — Lakshman M, Xu L, Ananthanarayanan V, Cooper J, Takimoto CH, Helenowski I, Pelling JC, Bergan RC Dietary genistein inhibits metastasis of human prostate cancer in mice.
Le Bail JC, Laroche T, Marre-Fournier F, Habrioux G Aromatase and 17β-hydroxysteroid dehydrogenase inhibition by flavonoids. Cancer Lett — Le Marchand L, Murphy SP, Hankin JH, Wilkens LR, Kolonel LN Intake of flavonoids and lung cancer.
J Natl Cancer Inst — Li YC Antioxidant activity of flavonoids from sweet potato vines in vitro. Adv Mater Res —— Li J, Cheng Y, Qu W, Sun Y, Wang Z, Wang H, Tian B a Fisetin, a dietary flavonoid, induces cell cycle arrest and apoptosis through activation of p53 and inhibition of NF-kappa B pathways in bladder cancer cells.
Basic Clin Pharmacol Toxicol 2 — Li X, Wang JN, Huang JM, Xiong XK, Chen MF, Ong CN, Shen HM, Yang XF b Chrysin promotes tumor necrosis factor TNF -related apoptosis-inducing ligand TRAIL induced apoptosis in human cancer cell lines. Toxicol In Vitro 25 3 — Lim SD, Sun C, Lambeth JD, Marshall F, Amin M, Chung L, Petros JA, Arnold RS Increased Nox1 and hydrogen peroxide in prostate cancer.
Prostate 62 2 — Liu G, Ding L, Luo C, Yang H, Yang D, Liang G, Wang L Protection against DNA damage and inhibition of lipid peroxidation by flavones from Eremosparton songoricum Litv Vass. Res Chem Intermed 32 2 — Liu EH, Qi LW, Li P Structural relationship and binding mechanisms of five flavonoids with bovine serum albumin.
Liu PX, Gao J, Chen YJ, Long W, Shen X, Tang WS Anticancer activity of total flavonoids isolated from Xianhe Yanling Recipe. Chin J Integr Med 17 6 — Lund TD, Munson DJ, Haldy ME, Setchell KDR, Lephart ED, Handa RJ Equol is a novel anti-androgen that inhibits prostate growth and hormone feedback.
Biol Reprod — Cancer Cell Int Manach C, Morand C, Demigne C, Texier O, Regerat F, Remesy C Bioavailability of rutin and quercetin in rats. Marchetti F, De Santi C, Vietri M, Pietrabissa A, Spisni R, Mosca F, Pacifici GM Differential inhibition of human liver and duodenum sulphotransferase activities by quercetin, a flavonoid present in vegetables, fruit and wine.
McCann SE, Moysich KB, Freudenheim JL, Ambrosone CB, Shields PG The risk of breast cancer associated with dietary lignans differs by CYP17 genotype in women. J Nutr 10 — McCann SE, Muti P, Vito D, Edge SB, Trevisan M, Freudenheim JL Dietary lignan intakes and risk of pre- and postmenopausal breast cancer.
Int J Cancer 3 — McRae JM, Kennedy JA Wine and grape tannin interactions with salivary proteins and their impact on astringency: a review of current research.
Drug Metab Dispos — Messina MJ, Persky V, Setchell KDR, Barnes S Soy intake and cancer risk; a review of the in vitro and in vivo data. Middleton E, Kandaswami C The impact of plant flavonoids on mammalian biology: implications for immunity, inflammation and cancer. In: Harborne JB ed The flavonoids, advances in research since Mitchell JH, Gardner PT, Mcphail DB, Morrice PC, Collins AR, Duthie GG Antioxidant efficacy of phytoestrogens in chemical and biological model systems.
Modak B, Torres R, Urzúa A Seasonal variation of the flavonoids pinocembrin and 3- O -methylgalangin, in the surface component mixture resinous exudates and waxy coating of Heliotropium stenophyllum.
J Chil Chem Soc 56 1 — Molepo RS Flavonoid induction of cytochrome P CYP in human esophageal carcinoma cells: implications for chemotherapy. Sc Thesis, University of the Witwatersrand, Johannesberg. Monasterio A, Urdaci MC, Pinchuk IV et al.
Nutr cancer — Moon YJ, Wang X, Morris ME Dietary flavonoids: effects on xenobiotic and carcinogen metabolism. Toxicol In Vitro 20 2 — Morris ME, Zhang S Flavonoid—drug interactions: effects of flavonoids on ABC transporters. Mueller SO, Simon S, Chae K, Metzler M, Korach KS Phytoestrogens and their human metabolites show distinct agonistic and antagonistic properties on estrogen receptor alpha and ER beta in human cells.
Toxicol Sci — Nakase I, Gallis B, Takatani-Nakase T, Oh S, Lacoste E, Singh NP, Goodlett DR, Tanaka S, Futaki S, Lai H, Sasaki T Transferrin receptor-dependent cytotoxicity of artemisinin—transferrin conjugates on prostate cancer cells and induction of apoptosis.
Nardini M, Cirillo E, Natella F, Scaccini C Absorption of phenolic acids in humans after coffee consumption. Neuhouser ML Dietary flavonoids and cancer risk: evidence from human population studies. Nutr Cancer 50 1 :1—7. Nijeveldt R, Nood EV, Hoorn DECV, Boelens PG, Norren KV, Leeawen PAMV Flavonoids: a review of probable mechanisms of action and potential applications.
Nothlings U, Murphy SP, Wilkens LR, Boeing H et al A food pattern that is predictive of flavonol intake and risk of pancreatic cancer. Am J Clin Nutr 88 6 — Ofer M, Wolffram S, Koggel A, Spahn-Langguth H, Langguth P Modulation of drug transport by selected flavonoids: involvement of P-gp and OCT?
Eur J Pharm Sci 25 2—3 — Ogbuewu IP, Uchegbu MC, Emenalom OO, Okoli IC, Iloeje MU Overview of the chemistry of soy isoflavones, potential threats and potential therapeutic benefits.
Electron J Environ Agric Food Chem 9 4 — Oh S, Kim BJ, Singh NP, Lai H, Sasaki T Synthesis and anti-cancer activity of covalent conjugates of artemisinin and a transferrin-receptor targeting peptide. Ohta T, Nakatsugi S, Watanabe K, Kawamori T, Ishikawa F, Morotomi M, Sugie S, Toda T, Sugimura T, Wakabayashi K Inhibitory effects of bifido-bacterium-fermented soy milk on PhIP-induced rat mammary carcinogenesis, with partial contribution of its component isoflavaones.
Oikawa T, Shimamura M, Ashino H, Nakamura O, Kanayasu T, Morita I, Murota S Inhibition of angiogenesis by staurosporine, a potent protein kinase inhibitor.
J Antibiot Tokyo — Okushio K, Matsumoto N, Kohri T, Suzuki M, Nanjo F, Hara Y Absorption of tea catechins into rat portal vein. Biol Pharm Bull — Olthof MR, Hollman PC, Buijsman MN, van Amelsvoort JM, Katan MB Chlorogenic acid, quercetinrutinoside and black tea phenols are extensively metabolized in humans.
Ørgaard A, Jensen L The effects of soy isoflavones on obesity. Exp Biol Med 9 — Med Oncol 27 4 — Parr AJ, Bolwell GP Phenols in the plant and in man. The potential for possible nutritional enhancement of the diet by modifying phenolic content or composition.
J Sci Food Agric — Pascual-Teresa D, Santos-Buelga S, Rivas-Gonzalo JC Quantitative analysis of flavanols in Spanish foodstuffs and beverages. Passamonti S, Terdoslavich M, Franca R, Vanzo A, Tramer F, Braidot E, Petrussa E, Vianello A Bioavailability of flavonoids: a review of their membrane transport and the function of bilitranslocase in animal and plant organisms.
Curr Drug Metab — Patel MJ A review of potential health benefits of flavonoids. Lethbridge Undergrad Res J 3 2. Peng W, Kuo SM Flavonoid structure affects the inhibition of lipid peroxidation in caco-2 intestinal cells at physiological concentrations.
J Nutr 7 — It increases the DNA exposure to mutagens. Stefani et al. reported that flavonoids can have inhibition effect against carcinogenesis. Apigenin, fisetin, and luteolin flavonoids have been used to inhibit cell proliferation effectively.
A variety of endogenous angiogenic and angiostatic factors have the responsibility for regulating angiogenesis. Flavonoids have the power to fight against angiogenesis. Lumen formation, endothelial cells migration, and their proliferation are the important steps in angiogenesis. Angiogenesis inhibitors can interfere with these steps.
Flavonoids play an essential role among the known angiogenesis inhibitors. The inhibition of protein kinases is the possible mechanism for the treatment of angiogenesis. These enzymes are involved in the process of signal transduction against angiogenesis.
Carcinogenesis, the multistep process of tumor development, primarily involves the acquisition of the hallmark capabilities of cancer namely sustaining proliferative signaling, shirking growth suppressors, fighting cell death, triggering invasion and metastasis, and inducing angiogenesis by the incipient cells.
Aberrations in multiple intracellular signaling cascades and progressive accumulation of mutations during carcinogenesis present considerable opportunities for the development of clinical interventions in preventing cancer initiation, treating neoplasms during premalignant stages, and inhibiting tumor progression.
Natural agents that can target the hallmarks of cancer have attracted the attention of several researchers due to their chemical diversity, structural complexity, inherent biologic activity, affordability, easy availability, and lack of substantial toxic effects.
The potential targets of chemopreventive agents include multiple signaling pathways such as ROS generation and signaling, cyclooxygenase-2 COX-2 and lipoxygenase LOX pathways, and numerous cellular molecules like XMEs, transcription factors, proteins involved in cell cycle, apoptosis, invasion and angiogenesis, and enzymes involved in epigenetic modifications.
Flavonoids are proved to be effective chemopreventive agents. The research study suggests that the medicinal plant, Glycyrrhiza inflata has anticancer activity and also does the mechanism of action on flavonoids. Licorice is the root of G.
inflata which contains more anticancer properties. Licorice total flavonoids LTFs are used effectively against cancer [ 31 ]. Flavonoids enter through the outer membrane. Bad, Bax, and Bak are the proapoptotic regulators.
Bcl-2 and Bcl-x are the apoptosis regulator proteins. Proapoptotic regulators and apoptosis regulator proteins release cytochrome c in the mitochondria Figure 6. Apaf1, dATP, and procaspase-9 are bound with cytochrome c to form the apoptosome.
Caspase is activated because of the cleavage of procaspase At the same time, death receptors can interrelate with procaspase-8 to create its active form. A bid can control programmed cell death and can also release cytochrome c. At the end, apoptosis is performed [ 32 ].
Flavonoids on apoptotic pathway. The intrinsic and extrinsic signaling pathways are involved in apoptosis. Cellular stress factors are involved in the intrinsic apoptotic pathway.
They include ROS generation, endoplasmic reticulum ER stress, growth factor deprivation, and ionizing radiation. All these cellular stress factors are responsible for releasing cytochrome c from mitochondria. Apoptosome is the formation of a cytosolic multiprotein complex. It contains the adapter protein apoptotic protease-activating factor 1 Apaf-1 , cytochrome c, and pro-caspase In the place of apoptosome, caspase-9 begins and activates caspase-3 which cleaves target proteins leading to apoptosis.
Pro-apoptotic e. The extrinsic pathway is a process whereby the involvement of ligation of a ligand occurs with corresponding receptors. Ligands, such as CD95L, CD95, and TNF, are bound to the corresponding receptors.
The corresponding receptor is a prototype death receptor. Fas associated via death domain FADD , pro-caspase 8, and FLICE-inhibitory protein FLIP are collectively called as DISC death-inducing-signaling-complex. DISC activates caspase-8 which can further activate caspase-3 and leads to apoptosis.
One of the other ligands is TNF tumor necrosis factor. The corresponding receptor is TNF-R. Complex I contains receptor-interacting protein 1 RIP 1 , TNF receptor-associated death domain TRADD , and telomeric repeat-binding factor 2 trf 2.
It is attached to the receptor itself. Complex II holds RIP 1, TRADD, FADD, and pro-caspase 8. It can be recruited from complex I. The instigation of pro-caspase-8, in turn, activates caspase Mitochondria produce numerous death signals which are needed by the extrinsic death pathway.
Caspase 8 activates the extrinsic pathway. It is able to link with an intrinsic pathway. It can also activate the apoptotic gene, Bid.
The intrinsic pathway is connected with the apoptotic genes such as Bax and Bak. The above apoptotic gene formation results in cytochrome c. Finally, apoptosis occurs Figure 7. Intrinsic and extrinsic signaling pathways. Quercetin and apigenin can inhibit melanoma cell growth.
These compounds have potential to fight against invasive and metastatic cancers. This study has been conducted and proved with mice [ 33 ]. In vitro studies have confirmed that some flavonoids could inhibit the cell growth of colon, prostate, liver, and breast cancer [ 34 ].
Flavonoids can suppress carcinogenesis and also prevent cancer. Thus, these studies confirm the effectiveness of flavonoids in preventing cancer [ 35 ]. Oral cancer was developed chemically and was treated with flavonoids in the rat using 4-nitroquinoline 1-oxide-induced model.
It was found later that flavonoid inhibited oral cancer. Kawaii et al. studied about some citrus flavonoids and found that they inhibited the proliferation of cancer cells such as lung carcinoma A and gastric TGBC11TKB cancer cell lines.
It did not affect the human normal cell lines. Cancer is considered as a genetic illness caused by mutated genes. It is implicated in cell proliferation and cell death. DNA damage may lead to cell death.
Three groups of genes are mainly involved in the cancer process. They are oncogenes damaged proto-oncogenes , the tumor suppressor genes, and the DNA repair genes. Mutated proto-oncogenes lead to oncogenes. They are the responsible genes to proliferate the cells. Tumor suppressor genes code for proteins especially protein p53 and act as checkpoints to cell proliferation or cell death.
They can persuade cell cycle arrest in a damaged cell. DNA repair genes can be mutated and lead to a failure in DNA repair [ 36 ]. Chemotherapy, radiotherapy, surgery, and some other therapies are available in order to control the risk level of the various cancers and to give a complete cure to the disease.
When cancer cells are spread in a human body, chemotherapy is preferred to kill the cancer cells mainly [ 36 ]. Abnormal Savda Munziq ASMq , a traditional Uyghur medicine, has anticancer activities.
TGF-β1 and TNF-α protein expression studies are conducted using Western blot. U27 tumor mice model is used for this study. Based on this study, CTX group showed a decreased level of TGF-β1 and TNF-α proteins. ASMq groups with different dosages expressed decreased TGF-β1 protein and were increased in TNF-α proteins.
Compared to CTX group, TGF-β1 protein expression of ASMq groups was decreased and protein level was increased in TNF-α [ 37 ]. The time period between and has witnessed 1. Twenty-five percent of death has also occurred due to the consequence of this disease [ 38 ].
The advent of modern technology and its advances have not considerably reduced mortality caused by cancer; it still remains a major threat. A study was conducted on men and women with regard to consumption of flavonoids and its anticancer activity. It was found that the association between the two was inverse.
Flavonoids can prevent cancers and cure this disease too. Flavonoids and isoflavonoids are highly antiproliferative, and their compounds come to be handy in curbing the cell cycle or induce apoptosis. Flavonoids are commonly nontoxic compounds. They can be used along with synthetic drugs which may have little toxic substances and side effects.
The effect of toxic substances in marketed drugs may be decreased due to flavonoid content in the combinational drugs.
Therefore, synergistic studies are more effective. Some flavonoids have a chemopreventive effect on nitrosamine-induced carcinogenesis. Many flavonoids protect the genome from chemical carcinogens.
They prevent cancers and also are able to cure the disease. This was proved by in vitro and in vivo studies. The authors like to extend their sincere appreciation to the Deanship of Scientific Research at King Saud University for its funding of this research through the Research Group project No RGP Licensee IntechOpen.
This chapter is distributed under the terms of the Creative Commons Attribution 3. Edited by Gonçalo Justino. Open access peer-reviewed chapter Flavonoids: Anticancer Properties Written By Duraipandiyan Veeramuthu, William Raja Tharsius Raja, Naif Abdullah Al-Dhabi and Ignacimuthu Savarimuthu.
DOWNLOAD FOR FREE Share Cite Cite this chapter There are two ways to cite this chapter:. Choose citation style Select style Vancouver APA Harvard IEEE MLA Chicago Copy to clipboard Get citation. Choose citation style Select format Bibtex RIS Download citation. IntechOpen Flavonoids From Biosynthesis to Human Health Edited by Gonçalo Justino.
From the Edited Volume Flavonoids - From Biosynthesis to Human Health Edited by Goncalo C. Justino Book Details Order Print. Chapter metrics overview 3, Chapter Downloads View Full Metrics. Impact of this chapter. Abstract Flavonoids are plant secondary metabolites.
Keywords flavonoids cancer dietary foods pathway epidemiological study. Introduction Flavonoids are plant-based secondary metabolites. Different groups of flavonoids Flavonoids are mainly classified into four major groups: flavanols, flavones, anthocyanidins, and isoflavonoids.
Epidemiological information for flavonoids Many studies on the distribution of diseases prove that flavonoids have positive effects in curbing cancer. Case-control study in cancer Two case-control studies were conducted in six counties in New Jersey cases of ovarian cancer and controls [ 13 ] and in the North-East United States cases and controls.
Gastrointestinal cancers A case study showed that there is an inverse association between flavanone intake and esophageal cancer, and this could reduce by the intake of citrus fruits. Pancreatic cancer Researchers analyzed the intake of flavonoids and the risk of pancreatic cancer during the study.
Colorectal cancer Isoflavone intake was inversely related to colorectal cancer risk in men and postmenopausal women. Inhibition of pro-oxidant enzymes NADPH oxidase I NOX 1 enzyme produces superoxide, which is overexpressed in colon and prostate cancer cell lines [ 15 ].
Flavonoids from Scutellaria species Wogonin and baicalein from Scutellaria species have been tested in a mouse for anticancer activity. Flavonoid compounds for cancer treatment 2.
Apigenin Apigenin has anti-mutagenic properties. Kaempferol Kaempferol has anticancer effects and acts as a chemopreventive agent. Quercetin and diosmin Quercetin is one of the dietary flavonoids, which suppresses tumor growth by inhibiting protein tyrosine kinase PTK.
Anticancer activity of flavonoids Fruits and vegetables are having an enormous amount of flavonoids, which have been used as cancer chemopreventive agents. Antitumor effects Reactive oxygen species ROS can harm DNA and lead to mutations.
Cancer chemoprevention Carcinogenesis, the multistep process of tumor development, primarily involves the acquisition of the hallmark capabilities of cancer namely sustaining proliferative signaling, shirking growth suppressors, fighting cell death, triggering invasion and metastasis, and inducing angiogenesis by the incipient cells.
Mechanism of action on flavonoids Flavonoids are proved to be effective chemopreventive agents. Dietary flavonoids on apoptotic pathway Flavonoids enter through the outer membrane. Role of intrinsic and extrinsic signaling pathways The intrinsic and extrinsic signaling pathways are involved in apoptosis.
In vivo and in vitro studies on cancer Quercetin and apigenin can inhibit melanoma cell growth. Flavonoids in cancer treatment Oral cancer was developed chemically and was treated with flavonoids in the rat using 4-nitroquinoline 1-oxide-induced model. Cancer process and cancer therapy Cancer is considered as a genetic illness caused by mutated genes.
Effects of ASMq on TGF-β1 and TNF-α protein expression Abnormal Savda Munziq ASMq , a traditional Uyghur medicine, has anticancer activities. Definition of cancer prevention The time period between and has witnessed 1. Flavonoids in cancer prevention A study was conducted on men and women with regard to consumption of flavonoids and its anticancer activity.
Overview on flavonoids Flavonoids are commonly nontoxic compounds. References 1. Havsteen BH. The biochemistry and medical significance of the flavonoids.
Flavonoods is a major public Athletes and gluten intolerance concern in both prveention and developing countries. Several plant-derived anti-cancer agents cqncer taxol, preventoon, vincristine, the campothecin derivatives, topotecan, irinotecan and etoposide are in clinical Hydrating and plumping all over the world. Other Athletes and gluten intolerance anti-cancer agents include flavopiridol, roscovitine, combretastatin A-4, betulinic acid and silvestrol. From this list Hydrating and plumping can well Flagonoids the Black pepper extract for enhancing absorption of polyphenols, flavonoids and their synthetic analogs in the treatment of ovarian, breast, cervical, pancreatic and prostate cancer. Flavonoids present in human diet comprise many polyphenolic secondary metabolites with broad-spectrum pharmacological activities including their potential role as anti-cancer agents. A positive correlation between flavonoids-rich diet from vegetables and fruits and lower risk of colon, prostate and breast cancers lead to a question that whether flavonoids mediate the protective effects as chemopreventive agents or can interact with different genes and proteins to play role in chemotherapy. The current review emphasizes onto the therapeutic potential of flavonoids and their synthetic analogs as anti-cancer agents by providing new insights into the factors, regulation and molecular mechanisms along with their significant protein interactions.
die Maßgebliche Antwort, neugierig...